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Abstract 
RACHEL LEA CREAGER-ALLEN: Autophosphorylation of the Response Regulator 
 PhoB 
(Under the direction of Robert Bourret and Ruth Silversmith) 
 
Two-component signal transduction systems are prevalent signal transduction 
systems in microorganisms. The essential elements of two-component systems are the 
sensor kinase and the response regulator. Response regulators typically receive a 
phosphoryl group in vivo from a sensor kinase, leading to a conformational change in the 
response regulator and a downstream effect. However, response regulators can also 
catalyze their own autophosphorylation with small-molecule phosphodonors. Using 
autophosphorylation to probe interactions between response regulators and small 
molecules might give insights potentially applicable to development of small molecule 
antibiotics.  
Prior to the work presented here, CheY was the only response regulator for which 
extensively characterized autophosphorylation kinetics had been published. The 
relationship between accumulation of phosphorylated CheY and small-molecule 
phosphodonor concentration remains linear up to the highest concentrations of 
phosphodonor tested, indicating very weak substrate binding. 
Here we describe extensive kinetic characterization of autophosphorylation of the 
Escherichia coli response regulator PhoB. Autophosphorylation kinetics differed greatly 
between PhoB and CheY. Specifically, the apparent rate constant for accumulation of 
PhoB-P appeared sigmoidal (Hill coefficient ~2) with respect to small-molecule 
phosphodonor concentration and to approach saturation. The data are consistent with a 
model in which PhoB-P forms a heterodimer with an unphosphorylated PhoB monomer, 
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which then autophosphorylates at an enhanced rate. Potential physiological implications 
of PhoB heterodimers are discussed.  Substitutions of nonconserved residues in the PhoB 
active site appeared to change the autophosphorylation reaction rate but not substrate 
binding. Further investigation of the link between PhoB dimerization and 
autophosphorylation using biolayer interferometry is proposed. 
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“The most rewarding things in life are often the ones that look like they cannot be done.” 
 -Arnold Palmer 
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Chapter 1: Introduction 
 
1.1 Signal transduction in bacteria 
Signal transduction is the conversion of an environmental stimulus (changes in 
either the extracellular or intracellular conditions) into a functional change within the 
cell, typically a change in the behavior of the cell or the level of gene transcription. All 
organisms must be able to adapt to changes in both the internal and external 
environments to adequately tune proteins and enzymes to complete the life cycle; 
therefore, signal transduction is essential for life and occurs in all types of living 
organisms. Typically, signal transduction occurs via a series of sequential events (for 
instance ligand binding to a protein, leading to a protein modification [e.g. 
phosphorylation, conformational change], followed by a downstream response). In order 
to respond to a complex diversity of stimuli, signal transduction in bacteria is very 
diverse (1) and the number of signaling systems typically varies with genome size and the 
complexity of the extracellular environment occupied by a particular microbial species 
(2-4).  
1.1.1 Two-component signal transduction systems 
One of the most prevalent signal transduction systems in bacteria is the two-
component signal transduction system. The essential components of two component 
systems are the sensor kinase and the response regulator (Figure 1.1). The sensor kinase 
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contains a variable input domain and a conserved histidine kinase domain, whereas the 
response regulator contains a conserved receiver domain and a variable output domain. 
Signal transduction typically commences upon detection of an environmental stimulus by 
the input domain of the sensor kinase (Figure 1.1). Upon detection, the sensor kinase 
typically uses ATP to autophosphorylate on a conserved histidine residue in the histidine 
kinase domain. The signal continues through the system when the phosphoryl group is 
transferred from the sensor kinase to a conserved aspartate residue in the receiver domain 
of the response regulator. To terminate the signal, the phosphorylated response regulator 
is dephosphorylated through autodephosphorylation (5), phosphatase-enhanced 
dephosphorylation (6,7), or reverse phosphotransfer (8). A divalent cation is required for 
both phosphorylation and dephosphorylation of the response regulator (9). Due to the 
great diversity of input and output domains, two-component systems are able to regulate 
many processes (1,10). 
1.1.2 Two-component signal transduction systems in the context of other signaling 
systems 
 Though two-component systems are some of the best characterized signaling 
systems in bacteria, they are not the only mode of signal transduction (Figure 1.2). 
Prokaryotes contain a signal transduction system that is simpler in design than the two-
component system, called the one-component system (Figure 1.2A). One-component 
signal transduction systems are widespread among both bacteria and archaea (1) and are 
highly represented in bacterial genomes (3,11), suggesting one-component systems are a 
dominant form of signal transduction in prokaryotes. The one-component system consists 
of a single protein containing both the stimulus sensing input domain and the output 
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domain that affects a downstream response (1,3). It is predicted that one-component 
systems bind ligand at the input domain, undergo a conformational change, and directly 
generate a response (11). Because the input and output domain of one-component 
systems are part of the same protein and the common predicted effect of one-component 
systems is transcription regulation (3,11), one-component systems are predicted to only 
respond to stimulus molecules within the cytosol.  
Two-component systems (Figure 1.2B) likely evolved from one-component 
systems by the addition of the phosphoryl transfer domains [histidine kinase domain in 
sensor kinase and receiver domain in response regulator] (11). This adaptation allowed 
for the output domain (contained within the response regulator) to be physically separated 
from the input domain (contained within the sensor kinase) and for the incorporation of a 
transmembrane sensor that can respond to events in the extracellular or periplasmic 
environment (1,3,11). Because a single sensor kinase can autophosphorylate and transfer 
phosphoryl groups to many response regulators, the separation of stimulus sensing and 
response in two-component systems also allowed for signal amplification. Linking of the 
input and output domains by a phosphotransfer reaction allows for signal integration 
(multiple stimuli yield a single cellular response), distribution (one stimulus yields 
multiple cellular responses), or any combination in between. Separation of the input and 
output domains further allowed for further evolution of more complex signaling cascades 
(termed phosphorelay systems) to occur by addition of additional phospho-acceptor and 
phospho-donor proteins (Figure 1.2C). 
Che-like signaling systems [Che  systems control chemotaxis, Che-like systems 
control transcription] (Figure 1.2D) are a modified form of two-component systems (11-
 4
13) and, at a minimum, contain a modified sensor kinase lacking an input domain, a 
response regulator lacking an output domain, a transmembrane receptor, and a scaffold 
protein that docks the receptor to the sensor kinase (11,12). Ligand interaction with 
transmembrane receptors affects autophosphorylation of the sensor kinase and 
subsequently the flow of phosphoryl groups from the sensor kinase to the response 
regulator. Bacteria are able to adapt to the extracellular environment through methylation 
and demethylation of the transmembrane receptor by auxiliary proteins, allowing cells to 
“forget” a constant environmental stimulus and to return to pre-stimulus activity levels. 
Because chemotaxis usually occurs via a biased random walk, Che-like signaling allowed 
bacteria to transition from passive sensing to active exploration of the environment 
(11,12). Che-like signaling systems also allowed for different ligands to affect the same 
cellular response. In E. coli, multiple transmembrane receptors respond to varying ligands 
(Tar responds to aspartate and maltose, Tsr responds to serine, Trg responds to galactose 
and ribose, and Tap responds to dipeptides) and interact with the sensor kinase CheA 
(14).  
1.1.3 The potential benefits of understanding two-component systems  
Two-component signal transduction systems are prevalent signaling systems in 
bacteria and there are multiple reasons to seek better understanding of the chemistry of 
the proteins involved. First, because chemical modification (especially phosphorylation) 
of proteins is widely employed by signaling proteins, understanding signaling by two-
component systems would give better understanding to signal transduction in general 
(10). Second, understanding how bacteria respond to the presence of specific molecules 
in the environment may allow for a better manipulation of many bacterial processes [e.g. 
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engineering biosensors, enhancing environmental remediation] (10). Third, two-
component systems are found in many eukaryotic and prokaryotic microorganisms as 
well as plants but are not found in higher eukaryotes (2). The lack of two-component 
systems in humans and animals makes two-component systems a potential target for 
antibiotics against microbial pathogens (10,15,16). 
Because both prokaryotic and eukaryotic signal transduction pathways participate 
in many important cellular processes, signaling systems may be potential targets for 
therapeutic agents (16). Many targeted cancer therapies work on proteins that are 
involved in human signal transduction pathways that regulate cell growth, cell division 
and response to external stimuli (17,18). Two major targets for anti-cancer therapeutics 
are the Ras/Raf/MEK/ERK signaling pathway (17) and the estrogen receptor signaling 
pathway (18). In both cases, disruption of the signaling pathway either through inhibition 
of a protein kinase or a hormone receptor leads to treatment of certain types of cancer. 
Although there are currently no approved therapeutics that inhibit bacterial signal 
transduction pathways, previous success at targeting human signaling systems suggests 
that bacterial signaling pathways might be potential targets for antibiotics. Recently, there 
have been some advances made in targeting two-component signal transduction systems 
using small molecule inhibitors. The PhoQ/PhoP two-component system is thought to 
regulate the ability of Salmonella enterica to infect epithelial cells and to live within 
phagocytic cells (19). The response regulator PhoP must dimerize in order to interact 
with DNA to regulate transcription. Eight small molecule inhibitors have been shown to 
interrupt PhoP dimerization and thus DNA binding (20). Another example of targeting 
two-component systems involves the QseC/QseB two-component system, which plays a 
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role in virulence of at least 25 plant and animal pathogens, including Enterohemorrhagic 
E. coli (21). The sensor kinase QseC is a receptor for autoinducer-3 produced by the 
gastrointestinal microbial flora or host epinephrine and norephinephrine; detection of the 
stimuli leads to induction of transcription of virulence factors. A small molecule inhibitor 
prevents ligand binding and autophosphorylation of QseC, stopping expression of 
virulence factors and markedly inhibiting virulence of several pathogens in animal 
models (22). 
 
1.2. Signaling by response regulator phosphorylation is due to conformational 
changes 
Two-component systems are able to regulate a very diverse set of cellular 
processes from simple metabolism to complex cellular development (1,10). How are two-
component signal transductions systems able to regulate such diverse cellular processes? 
To be able to understand regulation we must first discuss the conserved receiver domain 
structure of response regulators. The receiver domain (Figure 1.3) contains a conserved 
tertiary fold and approximately 25% amino acid sequence identity (10,15,23). The 
defining feature of the receiver domain is the (βα)5 topology with an active site 
containing both the site of phosphorylation and the divalent cation binding site (24,25). 
The receiver domain contains five invariable active site residues (Figure 1.3): the 
aspartate that is the site of phosphorylation, two acidic residues that coordinate the 
required divalent cation, and a threonine/serine and a lysine that form noncovalent bonds 
with the phosphoryl group. 
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The conserved receiver domain undergoes a conserved conformational change 
(15,26,27) [Figure 1.4]. Analysis of structures of numerous receiver domains shows that 
phosphorylation or binding of a phosphoryl group analog to the active site Asp leads to 
conformational rearrangements on the α4-β5-α5 surface (10,24,28). These 
conformational shifts occur via a conserved mechanism of allosteric communication 
between the site of phosphorylation and the functionally relevant α4-β5-α5 surface. 
Activation leads to reorientation of the two switch residues (the conserved 
threonine/serine in β4 and a tyrosine/phenylalanine in β5) towards the active site [Figure 
1.4B] (10,15). In the inactive conformation, the switch residues are outward facing with 
the tyrosine/phenylalanine exposed on the domain surface (10). In the inactive solvent-
exposed conformation, the tyrosine/phenylalanine sterically hinders interaction between 
the receiver domain and other proteins or domains of the same protein (28). In the active 
conformation, the threonine/serine rotates into the active site and forms a hydrogen bond 
with a phosphoryl group oxygen. The repositioning of the threonine/serine allows for 
movement of the β4α4 loop and stabilization of the tyrosine/phenylalanine side chain 
within a hydrophobic core (25). The conformational change leads to packing of other 
residues that stabilizes the active state, though the main changes between the inactive and 
active conformation are at the tyrosine/phenylalanine and in the β4α4 loop (15,28). 
Though it is typically said that the receiver domain is in equilibrium between an 
inactive and an active conformation, the conformational change is not a simple two-state 
process. Studying the µs-ms timescale motions of CheY using NMR showed that CheY 
does not undergo a concerted mechanism between two states (26). Because proteins are 
dynamic by nature, movement within the protein between two predominant states implies 
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that there are also intermediate states. Intermediate conformational states of CheY have 
been demonstrated crystallographically both in the presence (29,30) and absence (31) of 
effector protein. Similarly, molecular dynamic simulations of the conformational change 
of CheY show that rotation of the tyrosine/phenylalanine and the formation of the 
hydrogen bond between the threonine/serine and the phosphoryl group are independent 
(32). 
In the absence of phosphorylation, there is an intrinsic conformational equilibrium 
predominantly between the inactive and the active conformations, with the equilibrium 
greatly shifted towards the inactive conformation (Figure 1.5A). Upon phosphorylation, 
this conformational equilibrium is shifted primarily towards the active conformation, 
exposing the α4-β5-α5 interface. In single domain response regulators, the 
conformational change typically results in an interaction between the α4-β5-α5 interface 
and an effector protein (Figure 1.5B). In dimerizing response regulators (33-35), this 
conformational change is thought to allow two phosphorylated monomers to dimerize 
along the α4-β5-α5 surface (24) [Figure 1.5C]. As is true for all allosteric proteins, there 
are two popular models for how the link between phosphorylation and conformational 
change might work: the Koshland-Nemethy-Filmer (KNF) model and the Monod-
Wyman-Changeux (MWC) model (36). In the KNF model, phosphorylation of the 
response regulator induces a conformational change from the inactive to the active 
conformation. In the MWC model, the response regulator exists in multiple 
conformational states, with the equilibrium greatly shifted towards the inactive 
conformation. Phosphorylation preferentially occurs in and stabilizes the subpopulation 
of response regulators that are in the active conformation. It is currently thought that the 
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MWC model descibes what occurs with response regulator phosphorylation based on the 
following evidence (15,26): 1) Unphosphorylated response regulators have some ability 
to regulate downstream effects (37,38), indicating the presence of some response 
regulator in the active conformation. 2) Crystal structure of CheY that is not bound to a 
phosphoryl group analog includes tyrosine occupying both the active and the inactive 
rotomers (39). 3) The coupling of phosphorylation and conformational change within the 
receiver domain occurs in both directions. Just as phosphorylation of response regulators 
promotes the active conformation, increasing the population of response regulator in the 
active conformation (e.g. binding target ligand) increases the rate of autophosphorylation 
(40,41). 4) NMR shows the unphosphorylated receiver domain of NtrC is in equilibrium 
between the inactive and active conformation with the equilibrium skewed towards the 
inactive conformation (27). 
 
1.3 Response regulators self-catalyze phosphorylation and dephosphorylation 
chemistry  
Response regulators typically receive a phosphoryl group in vivo from a sensor 
kinase, leading to a conformational change in the receiver domain. The five conserved 
residues in the receiver domain (see above) catalyze both phosphorylation and 
dephosphorylation of the response regulator (24,25). In addition to catalyzing 
phosphotransfer from the sensor kinase, response regulators can also catalyze their own 
autophosphorylation with small-molecule phosphodonors [Table 1.1] (42-46). The 
mechanisms of autophosphorylation and phosphotransfer likely occur via the same 
substitution chemistry, so understanding autophosphorylation can give insight into the 
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more complex phosphotransfer reaction (25,46) without the complication of purifying the 
transmembrane sensor kinase (10). Furthermore, understanding autophosphorylation with 
small-molecule phosphodonors containing an N-P bond (PAM, MPI, DPI) may help 
distinguish between the contributions of the phosphorylated histidine and the remainder 
of the sensor kinase. Also, because autophosphorylation involves interaction between the 
response regulator and a small molecule, understanding interaction between the two 
might give insight into potential small molecule antibiotics. 
 
Table 1.1. Structures of small molecule phosphodonors 
Small molecule phosphodonor Structure at pH 7 
Acetyl phosphate (AcP) 
 
Carbamoyl phosphate  
 
Phosphoramidate (PAM) 
 
Monophosphoimidazole (MPI) 
 
Diphosphoimidazole (DPI) 
 
 
1.3.1 Autophosphorylation of the response regulator CheY is nonsaturable with 
respect to small molecule phosphodonor concentration 
Prior to the work presented in this dissertation, CheY was the only response 
regulator for which extensively characterized autophosphorylation kinetics had been 
published (40,42,44,46). CheY (Figure 1.3) is a single domain response regulator that 
participates in transmission of chemotaxis signals from transmembrane chemoreceptors 
to flagellar motor proteins. Phosphorylated CheY binds to FliM at the flagellar motor, 
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inducing a change in the direction of flagellar rotation. The model of CheY 
autophosphorylation kinetics [in scheme 1.1 with the phosphodonor PAM (43)] involves 
initial binding of phosphodonor to CheY to form a noncovalent complex (dissociation 
constant KS), followed by phosphorylation (rate constant kphos) and subsequent 
autodephosphorylation (rate constant kdephos). 
 
 
Scheme 1.1. Kinetic model of autophosphorylation of the response regulator CheY. 
 
CheY contains a tryptophan in the active site that can be used as a fluorescent probe to 
monitor the pre-steady state kinetics of autophosphorylation. Specifically, the tryptophan 
follows the accumulation of phosphorylated CheY (CheY-P) from scheme 1.1. The 
observed rate constant for the accumulation of CheY-P (kobs) is described by equation 
1.1, using terms from scheme 1.1 (43). In reactions that exhibit saturable kinetics, the 
concentration of small-molecule phosphodonor exceeds the dissociation constant for 
substrate binding ([PAM] > KS). As the concentration of small-molecule phosphodonor is 
increased, the observed rate of formation approaches a maximal value. Subsequent 
additions of small molecule will not result in an appreciable increase in the observed rate 
of accumulation. From a graph of the observed rate constant (kobs) versus small molecule 
concentration (Figure 1.6A), it is possible to determine KS and kphos. For CheY, though, 
the relationship remains linear up to the highest concentrations of phosphodonor tested 
(100 mM), indicating very weak substrate binding (KS > 500 mM) (40,42,46). For 
reactions where KS is unattainable experimentally, it is not possible to separate binding 
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from catalysis; it is only possible to measure the apparent bimolecular rate constant, 
kphos/KS (Figure 1.6B). For CheY, kphos/KS is ~10 M-1 s-1 for autophosphorylation with 
either acetyl phosphate or PAM at 25°C and 230 mM ionic strength (40,42,44,46). 
Amino acid substitutions were made to nonconserved active site residues of CheY 
thought to interact with the small-molecule phosphodonor leaving group; however, the 
relationship between kobs and phosphodonor concentration remained linear, even for 
mutants with a 103-fold rate enhancement (46) (Immormino, R.M, & Bourret, R.B., 
unpublished). 
kobs 
kphosPAM
KSPAM
 kdephos 
However, CheY is not a typical response regulator in several respects. CheY 
consists only of a receiver domain and thus does not contain a variable output domain. 
Also, CheY does not act as a transcriptional regulator and does not dimerize upon 
phosphorylation. 
 
1.4 Inorganic phosphate signaling in E. coli 
In this dissertation, we sought to further explore response regulator 
autophosphorylation kinetics by characterizing a response regulator that is more typical 
than CheY. PhoB is a member of the largest class of response regulators, termed the 
OmpR/PhoB family, which contains ~30% of annotated response regulators (47). The 
PhoR/PhoB system is a very well-characterized two-component signal transduction 
system that regulates the large number of genes in the pho regulon in E. coli (48). The 
pho regulon is required for the incorporation of a variety of phosphorus sources from the 
environment, with inorganic phosphate (Pi) being the preferred phosphorus source (49). 
1.1 
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Signal transduction by Pi requires seven proteins (48-50): inner membrane sensor kinase 
PhoR, response regulator PhoB, four components of the ABC transporter for high-affinity 
capture of Pi and low-velocity transport into cytosol (PstS, PstC, PstA, PstB), and the 
chaperone-like PhoR inhibitor PhoU. The likely in vivo mechanism for Pi signaling is 
(48): Pi binds to the transmembrane Pst complex when in excess and PhoU acts as a 
chaperone by interacting with both Pst and PhoR; PhoR is turned off and PhoB is not 
phosphorylated. When Pi is limiting, Pi is no longer bound to the Pst complex and PhoU 
dissociates from PhoR; PhoR autophosphorylates and PhoB is subsequently 
phosphorylated and thus regulates transcription. When Pi is in excess again, Pst, PhoU 
and PhoR interact and PhoB is dephosphorylated and dissociates from DNA.  
Like many response regulators, PhoB dimerizes through its receiver domain, 
allowing two output domains to come together and bind to a DNA-binding site on the 
promoter to activate transcription (50,51). PhoB binds to the repeats as a head-to-tail 
dimer (52), allowing for recruitment of the σ70 subunit (specifically by binding of the σ4 
domain) of E. coli RNA polymerase (53). There are a large number of PhoB binding sites 
on the E. coli genome, though only 31 genes have been shown to be directly controlled 
by the PhoR/PhoB two-component system (48). Nearly all of the genes regulated by 
PhoB play a role in the assimilation of Pi or alternative phosphorus sources, with the most 
strongly activated promoter being the pst operon that encodes the four Pst components 
and PhoU. The phoR and phoB genes are also regulated by PhoB; under Pi limitation, 
PhoB and PhoR concentrations increase over 100-fold (49). PhoB binds to a sequence on 
the DNA called a pho box: an 11 base pair repeat that replaces the -35 promoter sequence 
(53,54).  
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1.5 Characterization of PhoB autophosphorylation yields insights not inferred from 
CheY autophosphorylation 
Here, we present kinetic characterization of autophosphorylation of the E. coli 
response regulator PhoB. We found that the relationship between accumulation of PhoB-
P and the concentration of small-molecule phosphodonor appeared sigmoidal and to 
approach saturation (Chapter 2). Mathematical modeling and biochemical evidence 
suggest a link between PhoB dimerization and autophosphorylation. Substitutions made 
within the nonconserved residues in the active site of PhoB resulted in several with 
autophosphorylation kinetics that varied from wild type (Chapter 3). Any effects on 
autophosphorylation kinetics appear to be due to changes to the rates of phosphorylation 
as opposed to changes in substrate binding to PhoB. Further investigation of the 
formation of PhoB heterodimers (formed between one phosphorylated and one 
unphosphorylated monomer) is proposed (Chapter 4). The link between 
autophosphorylation and dimerization of the response regulator PhoB is related to the 
fields of autophosphorylation and two-component signaling in general (Chapter 5). 
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1.6 Figures 
 
Figure 1.1. Schematic representation of two-component signal transduction system. 
Two-component signal transduction systems are composed of a sensor kinase (purple) 
and a response regulator (green). Upon stimulus, the sensor kinase autophosphorylates on 
a conserved histidine. The phosphoryl group is transferred to a conserved aspartate in the 
response regulator. The phosphorylated response regulator can exert its downstream 
effects. 
  
 16 
 
Figure 1.2. Four classes of prokaryotic signal transduction systems. (A) One-
component signal transduction. Covalently linked stimulus sensing input domain (dark 
purple) and output domain (dark green) that affects a downstream response. (B) Two-
component signal transduction. Sensor kinase (variable input domain, conserved histidine 
kinase domain [light green]) and response regulator (conversed receiver domain [light 
purple], variable output domain) signal via phosphoryl transfer. (C) Phosphorelay 
system. At a minimum, a sensor kinase, a receiver domain (attached to sensor kinase or 
stand-alone), a histidine phosphotransferase, and a terminal response regulator. (D) Che-
like signaling system. At a minimum, a modified sensor kinase lacking an input domain, 
a response regulator lacking an output domain, a transmembrane receptor (orange), and a 
scaffold protein (red circle) that docks the receptor to the sensor kinase. 
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Figure 1.3. Ribbon representation of conserved receiver domain structure. The 
crystal structure shown is of E. coli CheY (PDBid 2CHE) as an example of the conserved 
tertiary structure and catalytically functional residues of receiver domains. Side chains for 
the following conserved active site residues are shown as sticks: Asp 57 (‘D’), Asp 12 & 
Asp 13 (‘DD’), Thr 87 (‘T’), and Lys 109 (‘K’). Also shown is the active site magnesium 
ion (magenta sphere).  
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Figure 1.4. Phosphorylation-linked conformational of receiver domain. (A) Overlay 
of inactive (purple, PDBid 2CHE) and active (green, PDBid 1FQW) receiver domain 
conformations with the side chains of the switch residues (Thr 87 and Tyr 106) and site 
of phosphorylation (Asp 57) shown. (B) Magnified view of switch residues in red box 
from (A). 
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Figure 1.5. Conformational equilibria of response regulators. In the absence of 
phosphorylation, the conformational equilibrium of the receiver domain is greatly shifted 
towards the inactive conformation (A). Phosphorylation shifts the conformational 
equilibrium greatly towards the active conformation. In single domain response 
regulators, this conformational change exposes the α4-β5-α5 interface that typically 
allows for interaction between the response regulator and an effector protein (B). In 
dimerizing response regulators, this conformational change is thought to allow two 
phosphorylated monomers to dimerize along the α4-β5-α5 interface in the receiver 
domain (C). 
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Figure 1.6. Plots of kobs versus small molecule concentration. (A) Observed rate 
versus substrate concentration for a reaction exhibiting saturable kinetics. (B) Observed 
rate versus substrate concentration for a reaction exhibiting nonsaturable kinetics. 
 
  
 
Chapter 2: A link between dimerization and autophosphorylation of the response 
regulator PhoB1 
 
2.1 Summary 
Response regulator proteins within two-component signal transduction systems 
are activated by phosphorylation and can catalyze their own covalent phosphorylation 
using small-molecule phosphodonors. To date, comprehensive kinetic characterization of 
response regulator autophosphorylation is limited to CheY, which follows a simple model 
of phosphodonor binding followed by phosphorylation. We characterized 
autophosphorylation of the response regulator PhoB, known to dimerize upon 
phosphorylation. In contrast to CheY, PhoB time traces exhibited an initial lag phase and 
gave apparent pseudo-first order rate constants that increased with protein concentration. 
Furthermore, plots of the apparent autophosphorylation rate constant versus 
phosphodonor concentration were sigmoidal, as were PhoB binding isotherms for the 
phosphoryl group analog BeF3¯ .  Successful mathematical modeling of the kinetic data 
necessitated inclusion of the formation of a PhoB heterodimer (one phosphorylated and 
one unphosphorylated monomer) with an enhanced rate of phosphorylation. Specifically, 
                                               
1
 The material in this chapter is from: Creager-Allen, R.L., Silversmith, R.E., Bourret, R.B. (2013) A link 
between dimerization and autophosphorylation of the response regulator PhoB. J. Biol. Chem. 288, 21755-
21769. 
(Creager-Allen, Silversmith, and Bourret designed research; Creager-Allen performed research; Creager-
Allen, Silversmith, and Bourret analyzed data; Creager-Allen, Silversmith, and Bourret wrote the paper.) 
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dimerization constants for the PhoB heterodimer and homodimer (two phosphorylated 
monomers) were similar, but the rate constant for heterodimer phosphorylation was ~10-
fold higher than for the monomer. In a test of the model, disruption of the known PhoBN 
dimerization interface by mutation led to markedly slower and non-cooperative 
autophosphorylation kinetics. Furthermore, phosphotransfer from the sensor kinase PhoR 
was enhanced by dimer formation. Phosphorylation-mediated dimerization allows many 
response regulators to bind to tandem DNA binding sites and regulate transcription.  Our 
data challenge the notion that response regulator dimers primarily form between two 
phosphorylated monomers, and raise the possibility that response regulator heterodimers 
containing one phosphoryl group may participate in gene regulation. 
 
2.2 Introduction 
Two-component signal transduction systems, present in both eukaryotic and 
prokaryotic microorganisms as well as plants, are nearly ubiquitous in bacteria with tens 
of thousands of two-component system proteins currently annotated in sequence 
databanks (2,55). The essential components of any two-component system are a sensor 
kinase and a partner response regulator. Detection of an environmental stimulus regulates 
the sensor kinase, often leading to autophosphorylation of a conserved histidine. The 
phosphoryl group is subsequently transferred to a conserved aspartate residue on the 
partner response regulator. Phosphorylation switches the response regulator to an active 
conformation (10), allowing the response regulator to exert its downstream effects. Many 
response regulators control transcription (47), typically by dimerization and binding to a 
symmetric DNA-binding site (24). To terminate the signal, response regulators 
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dephosphorylate through autodephosphorylation (5), phosphatase-enhanced 
dephosphorylation (6,7), or reverse phosphotransfer (8).  
All response regulators contain a conserved receiver domain and most also 
contain one or more variable output domains. The receiver domain (Fig. 2.1) has a 
conserved (βα)5 tertiary structure and contains the dimerization interface for many 
response regulators as well as the conserved active site that catalyzes both 
phosphorylation and dephosphorylation (24,25). The five invariable residues that 
compose the active site include a conserved aspartate that is the site of phosphorylation, 
two acidic residues that coordinate a divalent cation required for catalysis, a 
threonine/serine, and a lysine. In addition to catalyzing phosphotransfer from the sensor 
kinase, response regulators can also catalyze their own autophosphorylation with small-
molecule phosphodonors including phosphoramidate (H3N+–PO32-, PAM1), acetyl 
phosphate, and monophosphoimidazole (42-46).  
Although autophosphorylation has been qualitatively demonstrated for many 
response regulators, CheY is the only response regulator for which extensively 
characterized autophosphorylation kinetics have been published (40,42,44,46). The 
model of CheY autophosphorylation kinetics [in scheme 1 with the phosphodonor PAM 
(43)] involves initial binding of phosphodonor to CheY to form a noncovalent complex 
(dissociation constant KS), followed by phosphorylation (rate constant kphos) and 
subsequent autodephosphorylation (rate constant kdephos). 
 
 
Scheme 1. Kinetic model of autophosphorylation of the response regulator CheY. 
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For CheY, the pre-steady state pseudo-first order rate constant for the 
accumulation of phosphorylated CheY (CheY-P) upon mixing CheY with phosphodonor 
remains linear with respect to PAM or acetyl phosphate concentration up to the highest 
concentrations of phosphodonor tested (100 mM), indicating very weak binding (KS > 
500 mM) (40,42,46). Thus for CheY, it is only possible to measure the apparent 
bimolecular rate constant, kphos/KS, for accumulation of CheY-P, which is ~10 M-1 s-1 for 
autophosphorylation with either acetyl phosphate or PAM (40,42,44,46). However, CheY 
is not a typical response regulator in several respects. CheY consists only of a receiver 
domain and thus does not contain a variable output domain. Also, CheY does not act as a 
transcriptional regulator and does not dimerize upon phosphorylation. 
To further explore response regulator autophosphorylation kinetics, we sought to 
characterize a more typical response regulator. PhoB is a member of the largest class of 
response regulators, termed the OmpR/PhoB family, which contains ~30% of annotated 
response regulators (47). Like many response regulators, PhoB dimerizes through its 
receiver domain, allowing two output domains to come together and bind to a DNA-
binding site on the promoter to regulate transcription (51). PhoB can autophosphorylate 
with acetyl phosphate or PAM (35,56-58) and contains an active site tryptophan (Fig. 
2.1) that can be used as a fluorescent probe for both metal binding and 
autophosphorylation (35). 
Analysis of structures of numerous receiver domains shows that phosphorylation 
or binding of a phosphoryl group analog to the active site Asp leads to conformational 
rearrangements on the α4-β5-α5 surface (10,24,28). These conformational shifts occur 
via a conserved mechanism of allosteric communication between the site of 
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phosphorylation and the functionally relevant α4-β5-α5 surface. In dimerizing response 
regulators like PhoB (33-35), this conformational change allows two monomers to 
dimerize along the α4-β5-α5 surface (24) [Fig. 1.5]. The coupling of phosphorylation and 
conformational change within the receiver domain occurs in both directions. Just as 
phosphorylation of response regulators promotes the active conformation, increasing the 
population of response regulator in the active conformation (e.g. binding target ligand) 
increases the rate of autophosphorylation (40,41).  
The PhoB receiver domain (PhoBN) has been demonstrated to form two different 
types of dimers. The two PhoBN dimers have been extensively characterized both 
structurally and biochemically (59-62). As expected, a dimer along the α4-β5-α5 surface 
(here termed dimer 1) forms in the presence of a phosphoryl group analog (62) and 
represents the functional, phosphorylation-mediated dimer. Unexpectedly, metal binding 
alone supports a modified version of dimer 1 (60).  Phosphorylated full-length PhoB 
(PhoBF) dimer (dimer 1) has a dimerization constant of 5.1 µM (61) measured by 
analytical ultracentrifugation. A second PhoBN dimer, here termed dimer 2, forms along 
the α1-β5α5 loop-α5 surface (Fig. 1.5) and has been observed under crystallographic 
conditions in either the absence of metal and phosphorylation (59) or in the presence of 
just metal [single crystallographic conditions resulted in PhoBN monomers in both dimer 
1 and dimer 2 within the asymmetric unit (60)]. Dimer 2 may not be physiologically 
relevant due to a dimerization constant [>350 µM (61)] that is substantially higher than 
the in vivo concentration of PhoB (63).  
Here, we present kinetic characterization of autophosphorylation of the E. coli 
response regulator PhoB with the phosphodonor PAM. PhoB autophosphorylation 
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exhibited several kinetic features that were fundamentally different from those of CheY. 
In contrast to the linear relationship between the pseudo-first order rate constant for 
accumulation of CheY-P and PAM concentration, this relationship for PhoB appeared 
sigmoidal and to approach saturation. Furthermore, unlike CheY, apparent pseudo-first 
order rate constants for PhoB autophosphorylation showed a protein concentration 
dependence. Additional biochemical evidence, supported by mathematical modeling, 
indicated a link between formation of PhoB dimer 1 and autophosphorylation kinetics. 
We propose that a heterodimer formed between a phosphorylated monomer and an 
unphosphorylated monomer of PhoB plays a role in PhoB autophosphorylation kinetics. 
 
2.3 Experimental Procedures 
2.3.1 Cloning and site directed mutagenesis 
Genes encoding E. coli full-length PhoB (PhoBF, residues 1-256) and the N-
terminal receiver domain of PhoB (PhoBN, residues 1-127) were amplified using standard 
PCR methods from the pENTR-b0399 (phoB) plasmid (64), provided by Dr. Michael 
Laub (Massachusetts Institute of Technology). The gene encoding E. coli CheY was 
amplified using standard PCR methods from pRS3 (65). PCR products were inserted into 
the pET28a vector (Novagen) to generate constructs (PhoBF, pET28a·phoBF; PhoBN, 
pET28a·phoBN; CheY, pKC1) that encode proteins with a thrombin cleavable His6-tag at 
the N-terminus. After thrombin cleavage, the resultant proteins contain an additional Gly-
Ser-His at the N-terminus. Addition of the three small residues is unlikely to affect the 
activity of the PhoB constructs because the N-terminus is on the opposite side of the 
protein from the site of phosphorylation and is in a portion of PhoB that does not undergo 
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a conformational change between the inactive and the active conformation. The presence 
of the same three residues in CheY did not affect the rates of autophosphorylation by 
PAM (data not shown) or autodephosphorylation (66). Site directed mutagenesis was 
performed using Quikchange technology (Agilent Technologies). Wild type and 
mutagenized plasmids were transformed into E. coli strain BL21(DE3) for protein 
expression and purification.  
The Gateway Entry vector for phoR [pENTR-b0400 (64) encoding the soluble 
portion of E. coli PhoR (residues 193-431, throughout referred to as PhoR)] and the 
Gateway Destination vector (pML375) were provided by Dr. Michael Laub 
(Massachusetts Institute of Technology).The gene encoding PhoR was transferred from 
the entry vector into the destination vector using standard Gateway protocols (Invitrogen) 
to generate a construct (pDEST·phoR) that encodes a protein with a thrombin cleavable 
His6-tag at the N-terminus.  
2.3.2 Synthesis of phosphoramidate 
The potassium salt of phosphoramidate (PAM) was synthesized as described (67). 
2.3.3 Protein overexpression and purification 
For the purification of CheY, PhoBF, PhoBN, PhoBN F20D, and PhoR, one liter of 
LB (+30 µg/mL kanamycin) was inoculated with 2.5 mL of an overnight culture of the 
appropriate expression strain and grown at 37°C to an optical density at 600 nm of 0.4. 
The culture was then transferred to room temperature, induced with 0.5 mM IPTG and 
grown 8-10 hours. Cells were collected by centrifugation and resuspended in lysis buffer 
(50 mM Hepes, pH 7.0, 300 mM NaCl, 10 mM imidazole). The cells were lysed by 
sonication and cellular debris was removed by ultracentrifugation (45 minutes, 4°C, 
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37,000xg). The supernatant was passed over a Nickel-NTA agarose (Qiagen) column and 
the column was subsequently washed with wash buffer (50 mM Hepes, pH 7.0, 300 mM 
NaCl, 20 mM imidazole). Protein was eluted with elution buffer (50 mM Hepes, pH 7.0, 
300 mM NaCl, 150 mM imidazole). All eluted proteins except PhoR were incubated with 
human alpha-thrombin (1 unit/mL sample, Haematologic Technologies, Inc) overnight at 
4°C, followed by gel filtration over a Superdex 75 16/60 column in 50 mM Hepes, pH 
7.0, 100 mM KCl, 2 mM DTT, 10% (v/v) glycerol to remove the thrombin and cleaved 
His6-tag (for CheY, DTT was omitted from the gel filtration buffer). PhoR was further 
purified using a Superose 12 gel filtration column in 50 mM Tris, pH 7.5, 500 mM NaCl, 
and 10% (v/v) glucose. Aliquots of purified proteins were flash frozen in dry ice/ethanol 
and stored at -80°C. 
PhoBN R115D was expressed and purified similarly to the above procedure with 
slight modifications based on a published purification protocol (61). One liter of LB (+30 
µg/mL kanamycin) with 1 M sorbitol and 10 mM betaine was inoculated with 2.5 mL of 
an overnight culture in LB and grown at 37°C to an optical density at 600 nm of 0.4. The 
culture was transferred to room temperature, induced with 0.25 mM IPTG, and grown for 
17-20 hours. The cell pellet was resuspended in lysis buffer containing 140 µg Halt 
protease inhibitor cocktail (Thermo Scientific) followed by sonication, Nickel-NTA 
chromatography and thrombin cleavage as above. The Superdex 75 gel filtration buffer 
contained 50 mM Hepes, pH 7.0, 2 mM DTT, and 10% (v/v) glycerol. 
2.3.4 Fluorescence measurements 
All fluorescence measurements were made using a Perkin-Elmer LS-50B 
fluorimeter equipped with a magnetic stirring device and FLWinLab software. 
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Tryptophan fluorescence was measured at an excitation wavelength of 295 nm and an 
emission wavelength of 346 nm. Sample temperature was held at 25 ± 0.5°C by a 
circulating water bath. 
2.3.5 Equilibrium fluorescence measurements 
Tryptophan fluorescence was used to monitor binding of divalent cation (Mn2+ or 
Mg2+) or beryllium trifluoride (BeF3¯ ) to various PhoBN constructs. All ligand binding 
assays were performed in triplicate in a 1-cm x 1-cm quartz cuvette at an initial volume 
of 1.5 mL.  
Divalent cation binding was assayed similarly to a published protocol (68). PhoBN 
(5 µM) or PhoBN F20D (5 µM) in 100 mM Hepes, pH 7.0, was allowed to come to 
temperature equilibrium with constant magnetic stirring and the initial fluorescence 
emission measured. Then, small volumes of a concentrated stock of MnCl2 or MgCl2 
were incrementally added to the solution. After each addition, the solution was incubated 
for two minutes to ensure a homogenous mixture. Ten fluorescence measurements were 
taken (1 measurement/s) and the values averaged and corrected for dilution. Altogether, 
fluorescence was measured for fifteen concentrations of divalent cation ranging between 
5-1000 µM MnCl2 and between 0.25-5 mM MgCl2. 
For BeF3¯  binding, PhoBN (5 µM) or PhoBN F20D (5 µM) was incubated in 100 
mM Hepes, pH 7.0, 3 mM MnCl2, and 10 mM NaF with constant stirring to reach 
temperature equilibrium. Small volumes of a concentrated stock of BeCl2 were 
incrementally added to give concentrations between 1 and 100 µM. After each addition 
of BeCl2, the solution was incubated for two minutes. BeCl2 reacts with NaF to form a 
series of beryllium fluoride adducts, which should be dominated by BeF3¯  at 10 mM NaF 
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(69). Thus, the concentration of BeF3¯  is assumed to be equal to the concentration of 
BeCl2. Ten independent fluorescence measurements were taken (1 measurement/s) for 
each concentration of BeCl2 and the values averaged and corrected for dilution. To 
correct for non-specific interactions between PhoBN and BeCl2, titrations were also 
performed in the absence of NaF. There was a small increase in fluorescence upon the 
first addition of BeCl2, which was subtracted from the fluorescence intensity for the 
titrations that contained 10 mM NaF. 
The above protocols were modified slightly for measurements of ligand binding 
to PhoBN R115D. PhoBN R115D exhibited a modest time-dependent quench in 
fluorescence, which stabilized within 15 minutes, in response to changes in solution ionic 
strength. The initial solutions containing 5 µM PhoBN R115D in buffer were thus allowed 
to incubate for 30 minutes at 25°C. An additional control titration was carried out with 
KCl (0-15 mM) in lieu of Mn2+, Mg2+, or BeF3¯  to quantify the ionic strength response. 
For all titrations, solutions were incubated for 15 minutes after addition of ligand and 
before fluorescence measurements were taken. The changes in fluorescence due to 
changes in ionic strength as determined by KCl titration were subtracted from the 
fluorescence intensity at each concentration of ligand. For divalent metal and BeF3¯  
binding, the changes in fluorescence due to changes in ionic strength were less than 5% 
of the total change in fluorescence. 
For both divalent cation and BeF3¯  binding, plots of (I0-I) versus ligand 
concentration were constructed, where I0 is the fluorescence intensity with no added 
ligand and I is the fluorescence intensity at a given concentration of ligand. Plots of BeF3¯  
binding to PhoBN and PhoBN F20D were sigmoidal and data were fit to equation 2.1 
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(GraphPad Prism) to determine n, the Hill coefficient, and K1/2, the concentration of 
BeCl2 required to acquire half (I0-Imax).   
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For determining all other ligand binding constants, a standard one-site binding 
equation was used. 
2.3.6 Fluorescence measurements of reaction kinetics 
Tryptophan fluorescence was used to continuously monitor autophosphorylation 
of both CheY and various PhoB constructs with PAM. Observed rate constants for 
autophosphorylation of CheY at a given concentration of PAM decrease with increasing 
ionic strength of the solution (44). Thus, all reactions were performed at a constant ionic 
strength of 400 mM, which includes the concentration of buffer, divalent cation, PAM, 
and KCl. 
Fluorescence measurement of CheY autophosphorylation was similar to previous 
reports (40,43,46). Briefly, a rapid mixing device (Applied Photophysics RX2000) was 
used to mix equal volumes of 10 µM CheY (in 6 mM MnCl2 and 100 mM Hepes, pH 7.0) 
and PAM (20-300 mM in 100 mM Hepes, pH 7.0). Both CheY and PAM solutions were 
supplemented with KCl to give a final ionic strength of 400 mM. Because CheY and 
PAM solutions were mixed at a one-to-one (v/v) ratio, the concentrations of CheY, 
MnCl2 and PAM were decreased by half in the final reaction. Fluorescence was 
continuously monitored and time points recorded every twenty milliseconds. Reactions 
were performed in duplicate for each experimental condition. 
[2.1] 
 32 
Autophosphorylation reactions for PhoBF, PhoBN, and PhoBN F20D were carried 
out in a 1-cm x 0.4-cm quartz cuvette with manual mixing to initiate the reaction. The 
beginnings of the time traces were identical when measured using a stopped flow 
apparatus or the standard cuvette. However, the ends of the time traces showed variability 
when measured using the stopped flow apparatus, likely due to diffusion over the longer 
period of time required to achieve steady state for PhoB (up to 35 minutes). PhoBF (5 
µM), PhoBN (2.5-20 µM), or PhoBN F20D (5 µM) were incubated in 100 mM Hepes, pH 
7.0, 3 mM MnCl2, and varying concentrations of KCl to reach a constant ionic strength of 
400 mM (after PAM addition) with magnetic stirring to reach temperature equilibrium. 
The autophosphorylation reaction was initiated by addition of PAM (10-150 mM final 
concentration) to bring the final volume to 750 µL, followed by repetitive pipeting to mix 
(< 5 s), and fluorescence was continuously monitored. Time points were recorded every 
twenty or one hundred milliseconds. Reactions were performed in triplicate for each 
experimental condition. 
Autophosphorylation time traces of PhoBN R115D were measured in a 1-cm x 1-
cm quartz cuvette at a final volume of 1.5 mL. PhoBN R115D (10 µM) was incubated in 
6 mM MnCl2, 100 mM Hepes, pH 7.0, and 282 mM KCl at a volume of 750 µL for 30 
minutes with magnetic stirring. Due to the effect of ionic strength on PhoBN R115D 
fluorescence (see above), it was necessary to keep the ionic strength of the whole system 
at 400 mM throughout the experiment. For that reason, the autophosphorylation reaction 
was initiated by addition of an equal volume of PAM (20-300 mM) in 100 mM Hepes, 
pH 7.0, and varying concentrations of KCl to maintain a constant ionic strength of 400 
mM, followed by mixing by repetitive pipeting (< 5 s), and fluorescence was 
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continuously monitored. Because PhoBN R115D and PAM solutions were mixed at a 
one-to-one ratio, the concentrations of PhoBN R115D, MnCl2 and PAM were decreased 
by half. Time points were recorded every 0.5 s. Reactions were performed in triplicate for 
each experimental condition. 
2.3.7 Analysis of kinetic data 
Autophosphorylation reactions were performed under pseudo-first order 
conditions, with a large molar excess of PAM over protein. Fluorescence time traces 
reflected a continually changing reaction rate, as the amount of unreacted CheY or PhoB 
decreased while PAM concentration was essentially unchanged. All time traces were 
normalized by dividing the fluorescence intensities by the initial fluorescence intensity 
(I0) to generate relative fluorescence intensity (RFI). Replicate time courses for the same 
protein or PAM concentration were averaged. The averaged, normalized fluorescence 
intensities are referred to as ‘time traces’ for the rest of this document. Initial curve fits 
were made to a single exponential decay (GraphPad Prism). For CheY and PhoBN 
R115D, the time traces gave excellent fits to a single exponential and the resulting 
pseudo-first order rate constants were termed observed rate constants (kobs). For PhoBF, 
PhoBN, and PhoBN F20D, there were modest but systematic deviations from a single 
exponential decay. Therefore, we also tried fitting these data to a two-phase exponential 
decay, but the fits were indistinguishable from a single exponential. As described in 
Results, there was utility in using the single exponential fits for initial data analysis, so 
the rate constants derived from imperfect single exponential fits were termed apparent 
rate constants (kapp).  The simple kinetic model shown in scheme 1 implicates the 
relationship between the pseudo-first order rate constant kobs and individual kinetic 
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parameters, shown in equation 2.2 (43). For CheY·Mn2+, plots of kobs versus PAM 
concentration were linear, consistent with results obtained with CheY·Mg2+ (40,42,46). 
This result indicates that the dissociation constant between CheY·Mn2+ and PAM is much 
larger than the highest concentration of PAM used in the experiment (KS >> [PAM]), 
reducing equation 2.2 to equation 2.3. Thus the slope of the line is equal to the apparent 
bimolecular rate constant (kphos/KS). For PhoBN R115D, plots of kobs versus the 
concentration of PAM were also linear, and the slope was similarly used to determine 
kphos/KS. Plots of the pseudo-first order rate constant kapp versus the concentration of 
PAM for PhoBF, PhoBN, and PhoBN F20D appeared sigmoidal and were thus fit using a 
modified Hill equation (Graph Pad Prism), equation 2.4, where kmax is the maximum 
change in apparent rate constant, K1/2 is the PAM concentration required to reach the 
mid-point of the dose-response curve, n is the Hill coefficient, and kmin is the minimum 
apparent rate constant. 
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2.3.8 Mathematical modeling of PhoBN autophosphorylation time traces 
Mathematical modeling of PhoBN autophosphorylation time traces was performed 
using Dynafit software (70) to potentially explain several features of the kinetic data, 
including an apparent lag at the beginning of the PhoBN autophosphorylation time traces 
and the observation that protein concentration affected the apparent pseudo-first order 
rate constant for autophosphorylation. As described in Results, numerous models of 
increasing complexity were tried before choosing the model described below. In 
particular, the protein concentration dependence of normalized PhoBN time traces 
constrained the model significantly because it necessitated the inclusion of a reaction step 
whereby multiple molecules of PhoBN interact to give reaction species with altered 
phosphorylation kinetics. Thus, based on a large body of evidence documenting the 
dimerization of PhoBF and PhoBN (33-35,59-62), a comprehensive model of 
autophosphorylation kinetics of PhoB that included multiple versions of PhoB dimer 1 
with the possibility of differing autophosphorylation kinetics was considered (Scheme 2). 
In the model, a monomer (m) of PhoB can bind to a molecule of PAM with dissociation 
constant KS (m) and then phosphorylate with rate constant kphos (m), analogous to the first 
two steps in scheme 1 for CheY. A phosphorylated PhoB monomer can then interact with 
either another phosphorylated PhoB monomer to form a homodimer (PhoB-P:PhoB-P), 
or with an unphosphorylated PhoB monomer to form a heterodimer (PhoB:PhoB-P), with 
dimerization constants Kdimer (hom) and Kdimer (het), respectively. The heterodimer can 
then bind to a molecule of PAM with dissociation constant KS (het) and phosphorylate 
with rate constant kphos (het). All three phosphorylated species of PhoB can also 
dephosphorylate, with rate constants kdephos (hom), kdephos (het), and kdephos (m). 
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Dimerization of two unphosphorylated PhoB monomers (dimer 2) was excluded from the 
model due to a measured dimerization constant [378 µM (61)] that was much greater than 
the highest concentration of PhoB used in our experiments.  
 
 
Scheme 2. Reactions included in mathematical model of PhoB autophosphorylation. 
 
To fit the kinetic data to the model, the normalized fluorescence intensities for 
PhoBN autophosphorylation time traces were first multiplied by the protein concentration 
used in the experiment. Dynafit requires a conversion factor that translates the 
concentration of different PhoB species to the measured fluorescence responses. We 
established conversion factors based on the assumption that tryptophan fluorescence was 
quenched solely as a result of the conformational change that occurs upon PhoB 
phosphorylation or formation of the heterodimer, but not by PAM binding. Thus the 
species that are not primarily in the active conformation (PhoB and PhoB·PAM) were 
assigned a conversion factor equal to the initial fluorescence intensity divided by the 
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protein concentration. The species that are primarily in the active conformation (PhoB–P, 
PhoB:PhoB–P, PhoB·PAM:PhoB–P, and PhoB–P:PhoB–P) were assigned a conversion 
factor equal to the minimum fluorescence intensity for autophosphorylation of 5 µM 
PhoBN with 150 mM PAM (i.e. the time trace with the maximum quench in fluorescence 
intensity) divided by the protein concentration. The described assumptions for the 
conversion factors gave good fits. Alternative assumptions were also tested (e.g. PAM 
binding to PhoBN resulted in quenched tryptophan fluorescence). However, alternative 
conversion factors could not by themselves account for fundamental features of the 
kinetics, such as the lag phase observed in the time traces or the protein concentration 
dependence of the apparent pseudo-first order rate constant. 
An initial model composed of the nine reactions described above gave good fits 
for ten of the twelve autophosphorylation time traces representing different 
concentrations of protein or PAM. However, there were systematic deviations for the two 
experimental conditions with the slowest timescales for autophosphorylation (10 mM and 
20 mM PAM). Specifically, the rate and equilibrium constants predicted by Dynafit gave 
modeled time traces that had the expected initial lag phases; however, the modeled 
plateaus at long reaction times were up to 30% below the experimental data. Slow 
formation of a PhoB aggregate (PhoBa) was added to the model with a rate constant of 
kagg (m). To compensate for the higher plateau observed in the experimental time traces, 
the conversion factor for PhoBa was set to three times the initial fluorescence intensity 
divided by the protein concentration. This larger conversion factor is consistent with light 
scattering due to formation of a soluble aggregate. 
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Next, we set the following four parameters to experimentally measured values. 
Kdimer (hom) was set to the published value of 5.1 µM (61). [For all equilibrium 
constants, we assumed rapid equilibrium and set the kon rate constant equal to 1x106 M-1 
s-1 (71).]  The three autodephosphorylation rate constants were determined by monitoring 
the disappearance of [32P]PhoBN-P or [32P]PhoBN R115D-P over time (see Experimental 
Procedures below, data not shown). The rate constant kdephos (hom) was set equal to the 
rate constant determined for [32P]PhoBN-P (0.0003 s-1). Because PhoBN R115D cannot 
form dimer 1, kdephos (m) was set equal to the rate constant determined for [32P]PhoBN 
R115D-P (0.0002 s-1). Because the model does not include formation of the 
unphosphorylated PhoB dimer, autodephosphorylation of the heterodimer is equivalent to 
dimer dissociation followed by monomer dephosphorylation. For that reason, kdephos (het) 
was also set equal to the rate constant determined for [32P]PhoBN R115D-P. Note that the 
measured kdephos values for PhoBN are in close agreement with previously reported values 
for kdephos for PhoBF (63,68,72). 
The remaining six rate and equilibrium constants [KS (m), kphos (m), Kdimer (het), 
KS (het), kphos (het), kagg (m)] were then manually varied until the modeled time traces 
were similar to the raw time traces for autophosphorylation of 5 µM PhoBN with 60 mM 
PAM. These modeled values were then used as initial constants for global analysis of all 
of the time traces for PhoBN autophosphorylation (i.e. 2.5-20 µM PhoBN with 60 mM 
PAM and 5 µM PhoBN with 10-150 mM PAM). Nonlinear least-square regressions were 
performed to simultaneously fit the six adjustable rate and equilibrium constants: KS (m), 
kphos (m), Kdimer (het), KS (het), kphos (het), kagg (m). Perturbing the initial values for the 
rate and equilibrium constants did not affect the resultant output. The residuals that were 
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output by Dynafit were divided by protein concentration to allow for comparison between 
protein concentrations. 
2.3.9 Radiolabeling of PhoR using [γ-32P]ATP 
His6-tagged PhoR (230 µg) was reacted with 1 mM [γ-32P]ATP (18 Ci/mmol) in 
35 mM Tris, pH 8.0, 35 mM KCl, and 3.5 mM MgCl2 in a total volume of 200 µL for 30 
minutes at room temperature. The sample was passed over 100 µL prewashed 
nickel·NTA resin in a small centrifugal 0.22 µm filtration device and washed ten times 
with 400 µL wash buffer (50 mM Hepes, pH 7.0, 300 mM NaCl, 20 mM imidazole) to 
remove excess [γ-32P]ATP. The [32P]PhoR-P was eluted with 3x 400 µL elution buffer 
(50 mM Hepes, pH 7.0, 300 mM NaCl, 150 mM imidazole) and concentrated. The 
concentration of [32P]PhoR-P was determined using a Bradford assay with BSA 
standards. Purified aliquots of [32P]PhoR-P were stored at -20°C. 
2.3.10 Phosphotransfer from [32P]PhoR-P to PhoBN 
[32P]PhoR-P was thawed and diluted into 35 mM Tris, pH 8.0, 35 mM KCl and 3 
mM MnCl2 to give a final protein concentration of 1 µM and a final volume of 120 µL. A 
7.5 µL aliquot was removed and added to 7.5 µL 2x-SDS PAGE buffer for a zero time 
point. Either PhoBN or PhoBN R115D was added at a ten-fold molar excess (10 µM), 
mixed, and a series of 7.5 µL time points up to ten minutes were removed and 
immediately combined with 2x-SDS PAGE buffer. Samples were electrophoresed on 
18% polyacrylamide gels and the gels were subsequently dried. The amount of 
[32P]PhoR-P at each time point was determined by phosphorimaging. The percentage of 
[32P]PhoR-P remaining was plotted against time and then fit to a one-phase exponential 
decay to determine the rate constant for phosphotransfer. 
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2.3.11 Rate constants for [32P]PhoB-P autodephosphorylation 
His6-tagged PhoR (6 µM) was reacted with 1 mM [γ-32P]ATP (18 Ci/mmol) in 35 
mM Tris, pH 8.0, 35 mM KCl, and 3 mM MnCl2 in a total volume of 50 µL for 15 
minutes at room temperature. The sample was passed over 100 µL prewashed 
nickel·NTA resin in a small centrifugal 0.22 µm filtration device to bind His6-tagged 
PhoR and washed ten times with 400 µL of buffer containing 35 mM Tris, pH 8.0, 35 
mM KCl, and 3 mM MnCl2 to remove excess [γ-32P]ATP. A 100 µL sample of either 
PhoBN (30 µM) or PhoBN R115D (30 µM) in 35 mM Tris, pH 8.0, 35 mM KCl, and 3 
mM MnCl2 was added to the column and incubated for five minutes at room temperature. 
The sample was allowed to filter over the nickel·NTA resin and the non-bound material 
was collected. 7.5 µL samples were removed and added to an equal volume of 2x SDS-
PAGE buffer at the following time points: 5 min, 10 min, 15 min, 30 min, 45 min, 60 
min, 90 min and 120 min. Samples were electrophoresed on 18% polyacrylamide gels. 
The gels were dried and the amount of [32P]PhoBN-P at each time point was determined 
by phosphorimaging. The percentage of [32P]PhoBN-P remaining was plotted against time 
and then fit to a one-phase exponential decay to determine the rate constant for 
autodephosphorylation. 
 
2.4 Results 
2.4.1 Optimization of PhoB autophosphorylation reaction conditions 
A divalent cation bound in the receiver domain active site is essential for catalysis 
of both response regulator phosphorylation and dephosphorylation (9,43). Therefore, as a 
prerequisite for measuring PhoB autophosphorylation kinetics, it was necessary to 
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characterize the metal binding properties of the various PhoB proteins [full-length PhoB 
(PhoBF), the N-terminal receiver domain (PhoBN), PhoBN F20D, and PhoBN R115D] so 
that the occupancy of the metal binding site was known for subsequent 
autophosphorylation experiments. Tryptophan fluorescence measurements indicated that 
binding between Mg2+ and PhoBN occurred with a dissociation constant (KD) of 1.6 ± 0.2 
mM, in agreement with the reported KD for PhoBF Mg2+ binding of 2.0 ± 0.5 mM (68). 
However, the concentration of Mg2+ required to reach high levels of metal-bound PhoB 
(> 95%) led to visible precipitation of both PhoBN and PhoBF within the timescale of the 
autophosphorylation reactions.  
To avoid complications associated with precipitation, we searched for another 
metal ion that bound to PhoB and could support autophosphorylation. Although Mg2+ is 
most likely the divalent cation utilized by PhoB in vivo, Mg2+ and Mn2+ have similar size 
and preferred coordination number, geometry, and ligand type (73). Furthermore, Mn2+ 
supports autophosphorylation of the response regulator Spo0F with PAM (74), 
autophosphorylation of several sensor kinases, and phosphotransfer from a sensor kinase 
to a response regulator in vitro (75-77). Binding of Mn2+ to both PhoBF and PhoBN was 
much tighter than Mg2+, with a KD of 82 ± 6 µM and 70 ± 4 µM, respectively. Mn2+ 
bound to PhoBN F20D and PhoBN R115D with similar affinities (KD of 51 ± 5 µM and 20 
± 8 µM, respectively). Furthermore, Mn2+ was highly capable of mediating PhoBN 
autophosphorylation and the concentration of Mn2+ required for > 95% occupancy of the 
metal binding site (3 mM MnCl2) did not lead to visible precipitation. Thus, the standard 
conditions for all autophosphorylation reactions in this study included 3 mM MnCl2 to 
ensure high occupancy of the metal binding site. Autophosphorylation of CheY was also 
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readily catalyzed by 3 mM Mn2+ (see below); thus, all autophosphorylation experiments 
were done in parallel for PhoB and CheY to rule out the possibility that any novel 
characteristics of PhoB autophosphorylation were due to the use of Mn2+ as opposed to 
Mg2+. 
The visible precipitation that occurred between Mg2+ and PhoB was more severe 
for PhoBF than for PhoBN. Though no visible precipitation occurred in solutions 
containing Mn2+ and either PhoBF or PhoBN, we wanted to take every measure to 
minimize formation of aggregates during autophosphorylation experiments. For that 
reason, the majority of the autophosphorylation reactions were performed using the 
highly soluble PhoBN. As expected from previous work (78), the removal of the DNA-
binding domain did not affect autophosphorylation of PhoB (see below).  
2.4.2 Normalized autophosphorylation time traces for PhoBN displayed a visible lag 
phase and a protein concentration dependence 
Autophosphorylation of both PhoBN and CheY at various PAM and protein 
concentrations were monitored by continuous measurement of tryptophan fluorescence. 
In all cases, PAM concentration exceeded protein concentration by at least three orders of 
magnitude, so the reactions occurred under pseudo-first order conditions. For both CheY 
and PhoBN, autophosphorylation was initiated by the addition of PAM, which resulted in 
a time-dependent quench in fluorescence that eventually leveled out (Fig. 2.2A-D). The 
fluorescence intensity is a relative measure of the process of the reaction from all 
unphosphorylated CheY or PhoBN (intensity at zero time) to a steady state level of 
phosphorylated CheY or PhoBN (intensity after steady state is achieved). Achievement of 
steady state indicates equal rates of autophosphorylation and autodephosphorylation. 
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Because the absolute magnitude of the initial fluorescence intensity varied for individual 
reactions (especially for different protein concentrations), time traces (Fig. 2.2) were 
normalized by dividing by the initial fluorescence intensities and are reported as relative 
fluorescence intensities (RFI).  
As expected, the time traces for CheY·Mn2+ autophosphorylation (Fig. 2.2A) 
displayed similar properties as those reported for CheY·Mg2+ (42,44). The shapes of the 
time traces for CheY·Mn2+ autophosphorylation were the same as for CheY·Mg2+ and 
occurred on a similar time scale (20-100 s). Also, the maximum quench in fluorescence 
due to autophosphorylation was ~50% for both CheY·Mn2+ and CheY·Mg2+.  Because of 
the pseudo-first order reaction conditions employed ([PAM] >> [CheY]) and the fact that 
fluorescence is a measure of the relative progress of the reaction, increasing the 
concentration of PAM resulted in a shift of the time traces to shorter reaction times (Fig. 
2.2A) but varying the concentration of CheY did not affect the time frame of the 
normalized time traces (Fig. 2.2C). 
However, comparison of autophosphorylation time traces for CheY (Fig. 2.2A) 
and PhoBN (Fig. 2.2B) revealed three evident differences. First, autophosphorylation of 
PhoBN was markedly slower than autophosphorylation of CheY, although the PhoBN 
time traces were still dependent on PAM concentration. For example, at 60 mM PAM, it 
took approximately 500 s for autophosphorylation of PhoBN to reach steady state, while it 
only took approximately 35 s for CheY. Second, the PhoBN autophosphorylation time 
traces displayed a visible lag phase (Fig. 2.2B – inset) that was not present in time traces 
for CheY autophosphorylation (Fig. 2.2A – inset). This lag was most evident during the 
first 100 seconds of the autophosphorylation time traces for 40 mM and 60 mM PAM. 
 44 
Finally, the half-life of the normalized autophosphorylation time traces of PhoBN clearly 
decreased with increasing protein concentration (2.5-20 µM) (Fig. 2.2D); however, CheY 
autophosphorylation time traces did not show a protein concentration dependence (Fig. 
2.2C).  
Both the lag and the protein concentration dependence of normalized time traces 
suggested that PhoBN autophosphorylation occurred with a more complex kinetic 
mechanism than CheY. Protein concentration dependence was inconsistent with a 
reaction in which a single molecule of PhoBN participates, but was consistent with a 
reaction that involves interactions between two or more PhoBN molecules. The PhoBN 
protein concentration dependence, in particular, suggested that interactions between 
PhoBN monomers play a role in the kinetic mechanism of PhoBN autophosphorylation. 
2.4.3 Initial analysis of PhoBN autophosphorylation suggested positive cooperativity 
with respect to PAM 
To analyze the kinetics of autophosphorylation more quantitatively, we fit the 
autophosphorylation time traces to a one-phase exponential decay and plotted the 
resultant rate constants against PAM concentration. For CheY, the time traces fit 
extremely well to a one-phase exponential decay (Fig. 2.3A), with low residuals 
[difference between data and curve fitting] (< ±0.25%) that displayed no obvious pattern. 
The CheY rate constants from these fits were termed kobs. For CheY·Mn2+, the plot of kobs 
versus PAM concentration was linear, consistent with results obtained with CheY·Mg2+ 
(40,42,46), and the slope of the plot was equal to kphos/KS. The kphos/KS for reaction of 
CheY·Mn2+ with PAM was 2.2 ± 0.04 M-1 s-1, which was 1/2 to 1/3  the kphos/KS of 6.1 M-
1
 s-1 for reaction of CheY·Mg2+ [after corrections for ionic strength (46)]. 
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In contrast to CheY and consistent with the visible lag, the PhoBN 
autophosphorylation time traces exhibited systematic deviations from a one-phase 
exponential decay (Fig. 2.3B). The residuals for PhoBN followed a pattern and were 4-
52x larger than for CheY throughout the entire time course (Fig. 2.3A and 2.3B – lower 
panel). Despite the systematic deviations from a single exponential decay, R2 values for 
fitting PhoBN autophosphorylation time traces with a one-phase exponential decay were 
greater than 0.98. Rate constants obtained from the single exponential fits were used to 
estimate the overall rate of acquisition of steady state; however, due to the systematic 
deviations, we labeled these apparent rate constants kapp and used these values as an 
initial tool for analyzing the data. 
A plot of kapp versus PAM concentration for PhoBN (Fig. 2.3D) differed from the 
plot of kobs versus PAM concentration for CheY (Fig. 2.3C) in two ways. First, the plot of 
kapp versus PAM concentration for PhoBN fit to a sigmoidal dose-response curve with a 
Hill coefficient of 2.1 ± 0.2, which suggested that autophosphorylation of PhoBN 
exhibited some sort of positive cooperativity. The apparent positive cooperativity 
indicated communication between PhoBN active sites, such that autophosphorylation of 
one active site led to enhanced autophosphorylation kinetics at other sites, another 
suggestion that multimerization affects the rate of autophosphorylation of PhoBN. 
Second, in contrast to kobs for CheY, which showed no signs of saturating at the PAM 
concentrations used, kapp for PhoBN appeared to saturate at high PAM concentrations.  
Previous work on PhoB autophosphorylation showed that removal of the DNA-
binding domain did not affect the rate of PhoB autophosphorylation with 20 mM PAM 
(78). As expected, PhoBF autophosphorylation time traces with multiple PAM 
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concentrations also showed a visible lag (Fig. 2.4A) and protein concentration 
dependence (data not shown) similar to PhoBN. Also, plots of kapp versus PAM 
concentration for PhoBF (Fig. 2.4B) were nearly superimposable on PhoBN (Fig. 2.3D, 
Hill coefficient of 2.1 ± 0.3) and also appeared saturable. Thus, the kinetic properties 
exhibited by PhoBN were not due to removal of the DNA-binding domain.  
2.4.4 Beryllium trifluoride binding to PhoBN displayed positive cooperativity 
The plot of kapp versus PAM concentration for PhoBN (Fig. 2.3D) used rate 
constants derived from curve fits that systematically deviated from a single exponential 
decay. Thus, we sought an alternate method of assessing communication between PhoBN 
active sites by examining binding of a phosphoryl group analog. BeF3¯  binds to the active 
site of response regulators and mimics the Asp-phosphate linkage of phosphorylated 
response regulators (28,62,79). A plot of the quench in PhoBN tryptophan fluorescence 
versus BeF3¯ concentration (Fig. 2.5) was also sigmoidal with a Hill coefficient of 1.8 ± 
0.2. The positive cooperativity exhibited in BeF3¯  binding lends credibility to the 
apparent cooperativity of PhoBN autophosphorylation kinetics (Fig. 2.3D). Also, with a 
K1/2 for BeF3¯  binding to PhoBN in the low micromolar range (44 ± 4 µM), the 
concentrations of BeF3¯  required to reach saturation were approximately three orders of 
magnitude lower than PAM concentrations needed, further reducing the possibility that a 
small amount of invisible aggregation could be affecting the PhoBN fluorescence signal. 
2.4.5 Mathematical modeling supported a link between dimerization and 
autophosphorylation of PhoBN 
In an attempt to account for the lag in the time traces and the protein 
concentration dependence of PhoBN autophosphorylation, we utilized mathematical 
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modeling software to construct a model of autophosphorylation. We began with a model 
that was similar to the kinetic model of CheY autophosphorylation (scheme 1) and 
included PAM binding, phosphorylation and dephosphorylation of PhoBN. This model 
was unable to account for either the lag of the autophosphorylation time traces or the 
protein concentration dependence, even when slow PAM binding or a variety of 
fluorescence intensity conversion factors were considered, suggesting a more complex 
kinetic mechanism of PhoBN autophosphorylation. The protein concentration dependence 
of PhoBN autophosphorylation, the visible lag in the PhoBN autophosphorylation time 
traces, the cooperative relationship between kapp and PAM concentration, and the 
sigmoidicity of BeF3¯  binding to PhoBN all suggested that there was a relationship 
between multimerization and autophosphorylation of PhoBN. Specifically, the protein 
concentration dependence of autophosphorylation rate constants demanded that multiple 
PhoBN molecules participated in the autophosphorylation reaction and the lag suggested 
the existence of an step early in the reactions that, once completed, resulted in faster 
autophosphorylation. PhoB is known to dimerize when phosphorylated, so we next 
included formation of a homodimer (PhoBN-P:PhoBN-P) in the model. This too was 
unable to account for the protein concentration dependence of autophosphorylation and 
the lag in the PhoBN autophosphorylation time traces, suggesting an even more complex 
mechanism.  
To account for all aspects of the autophosphorylation data, formation of a PhoBN 
heterodimer (PhoBN-P:PhoBN) was fundamental to the model.  The resultant ten-step 
kinetic model (Scheme 2, Fig. 2.6, see Experimental Procedures for extensive details) 
included the formation of both the PhoBN homodimer (PhoBN-P:PhoBN-P) and the 
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PhoBN heterodimer (PhoBN-P:PhoBN) and the possibility of differing 
autophosphorylation kinetics (KS and kphos) for the PhoBN monomer and the PhoBN 
heterodimer. Four out of the ten kinetic parameters were set to constants obtained 
experimentally to limit the number of variables that were subject to change by Dynafit 
software.  
All twelve time traces for autophosphorylation [i.e. 5 µM PhoBN with 10-150 mM 
PAM (Fig. 2.2B) and 2.5-20 µM PhoBN with 60 mM PAM (Fig. 2.2D)] were 
simultaneously fit to the model by global analysis using Dynafit software (Fig. 2.7). The 
global analysis of the PhoBN autophosphorylation time traces succeeded in fitting all data 
and a single set of predicted kinetic constants (Fig. 2.6) gave simulated time traces that 
overlaid well with all twelve of the PhoBN autophosphorylation time traces. Formation of 
the PhoB aggregate was an extremely slow process with a rate constant [kagg (m)] at least 
two orders of magnitude slower than either the rate constant for phosphorylation of the 
monomer [kphos (m)] or the heterodimer [kphos (het)]. Furthermore, excluding aggregation 
from the model did not greatly affect ten of the twelve autophosphorylation time traces. 
This was consistent with slow formation of a very small amount of soluble aggregate.  
The rate and equilibrium constants generated by computer modeling were 
consistent with a link between PhoBN dimerization and autophosphorylation. 
Specifically, formation of a PhoBN heterodimer (PhoBN-P:PhoBN) and different 
autophosphorylation properties of the heterodimer compared to the monomer were 
fundamental to the model.  Not only was inclusion of the heterodimer essential to fit the 
data, it was essential that the dimerization constant for the heterodimer [Kdimer (het)] had 
to be in the low micromolar range, similar to the dimerization constant for formation of 
 49 
the homodimer [Kdimer (hom), 5.1 µM]. In addition, kphos (het) had to be at least ten-fold 
faster than kphos (m). Dimerization constants in the same range as the protein 
concentration used in the experiments account for the protein concentration dependence 
of kapp. The difference between kphos (m) and kphos (het) accounts for the lag in the 
autophosphorylation time traces. Even modest modifications (± 50%) to the rate and 
equilibrium constants predicted by Dynafit led to poor fits to the autophosphorylation 
data. 
2.4.6 Disruption of the physiologically relevant dimer 1 interface of PhoBN impeded 
autophosphorylation 
Crystallographic evidence shows that PhoBN is able to dimerize at two different 
dimerization interfaces (59,60,62), the α4-β5-α5 surface (dimer 1) and the α1-β5α5 loop-
α5 surface (dimer 2) [Fig. 2.1]. To more directly test the potential link between dimer 
formation and autophosphorylation of PhoBN, we characterized autophosphorylation 
kinetics of PhoBN variants containing previously characterized amino acid substitutions 
known to disrupt dimer formation (61). Replacement of Arg 115 with Asp (PhoBN 
R115D) disrupted the electrostatic interaction between residues Arg 115 and Asp 101 in 
the dimer 1 interface. Replacement of Phe 20 with Asp (PhoBN F20D) disrupted the 
hydrophobic dimerization interface of dimer 2. 
Autophosphorylation of PhoBN F20D (dimer 2 mutant) with varying PAM 
concentrations displayed kinetics similar to wild type PhoBN. The autophosphorylation 
time traces exhibited a visible lag at the beginning of the time traces similar to wild type 
PhoBN (Fig. 2.4A). A plot of kapp versus PAM concentration for PhoBN F20D also fit to a 
sigmoidal curve with a Hill coefficient of 1.8 ± 0.2 (Fig. 2.4B), implying positive 
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cooperativity of autophosphorylation similar to wild type PhoBN. Therefore, the 
cooperativity of autophosphorylation of wild type PhoBN was not likely due to formation 
of a dimer along the non-physiological dimer 2 interface. 
In contrast, autophosphorylation of PhoBN R115D (dimer 1 mutant) with PAM 
occurred over a much longer timescale than wild type PhoBN and did not exhibit a visible 
lag at the beginning of the time traces (Fig. 2.4A-inset). The plot of kobs versus PAM 
concentration for PhoBN R115D (Fig. 2.4B) showed no signs of sigmoidicity and fit to a 
linear regression. Thus, disruption of the physiologically relevant PhoBN dimer 1 
interface resulted in slow autophosphorylation kinetics that were not cooperative. This 
result supported the link between dimerization and autophosphorylation of PhoBN and, 
furthermore, identifies the dimer 1 interface as the functionally relevant dimerization 
surface in autophosphorylation. Putting the mutant results together with previous 
observations and modeling, we propose that autophosphorylation kinetics of wild type 
PhoBN reflect the formation of a heterodimer along the dimer 1 interface, which leads to 
an enhanced rate constant for phosphorylation of the PhoBN heterodimer compared to the 
PhoBN monomer.  
2.4.7 Beryllium trifluoride binding to the physiologically relevant dimer 1 mutant 
PhoBN R115D was not cooperative 
To further investigate the role of dimer formation on the cooperativity of wild 
type PhoBN kinetics, we characterized the BeF3¯  binding properties of PhoBN R115D and 
PhoBN F20D. Binding of BeF3¯  to PhoBN F20D was cooperative with a Hill coefficient 
(2.0 ± 0.1) and binding constant (51 ± 3 µM) similar to wild type PhoBN (Fig. 2.5). In 
contrast, binding of BeF3¯  to PhoBN R115D was not cooperative and displayed a much 
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weaker binding constant than wild type PhoBN (Fig. 2.5). Because disruption of dimer 1 
eliminated the cooperativity of BeF3¯  binding to PhoBN, the cooperativity of BeF3¯  
binding to wild type PhoBN was likely due to the formation of a dimer along the dimer 1 
interface. 
2.4.8 Phosphotransfer from [32P]PhoR-P to wild type PhoBN was faster than to 
PhoBN R115D 
To determine if there was a link between the formation of the PhoBN dimer and 
phosphotransfer from the histidine kinase PhoR, the rate constants for  phosphotransfer 
from [32P]PhoR-P to wild type PhoBN and PhoBN R115D were determined by monitoring 
the time-dependent disappearance of [32P]PhoR-P in the presence of ten-fold molar 
excess PhoBN (Fig. 2.8). Phosphotransfer from [32P]PhoR-P to wild type PhoBN was 
approximately five-times faster than phosphotransfer from [32P]PhoR-P to PhoBN 
R115D, with bimolecular rate constants of 77,000 ± 5,000 M-1 s-1 and 16,000 ± 1,000 M-1 
s-1, respectively. Therefore, both PhoBN autophosphorylation with PAM and 
phosphotransfer from [32P]PhoR-P to PhoBN were enhanced by the formation of dimer 1. 
Furthermore, accumulation of radiolabeled phosphoryl group on PhoBN R115D occurred 
in a time dependent manner to a similar extent as wild type PhoBN (Fig. 2.8) indicating 
functional PhoBN R115D protein.  
 
2.5 Discussion 
A central observation here was that in contrast to CheY, PhoBN and PhoBF 
autophosphorylation kinetics exhibited properties indicative of communication between 
active sites from different monomers. Numerous lines of evidence supported the notion 
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that association of PhoB monomers to form heterodimers (one phosphorylated and one 
unphosphorylated monomer) affected autophosphorylation kinetics, including the protein 
concentration dependence of the normalized autophosphorylation time traces (Fig. 2.2D), 
the systematic deviation of the autophosphorylation time traces from a one-phase 
exponential (Fig. 2.3B), and the sigmoidicity of the plot of kapp versus PAM 
concentration (Fig. 2.3D). Binding of the phosphoryl group analog BeF3¯  to PhoBN was 
sigmoidally dependent on BeF3¯  concentration (Fig. 2.5) also indicating communication 
between PhoBN active sites. As predicted by a reaction scheme in which heterodimers 
play a role in autophosphorylation kinetics, disruption of the dimer 1 dimerization 
interface by the previously characterized R115D amino acid substitution (61) greatly 
reduced the rate of PhoBN autophosphorylation (Fig. 2.4B) and eliminated cooperativity 
in both autophosphorylation and BeF3¯  binding (Fig. 2.5).  
2.5.1 Successful mathematical modeling of autophosphorylation data provided 
insights into the PhoB reaction mechanism 
After testing multiple models of increasing complexity, we developed a scheme 
that linked autophosphorylation and dimerization of PhoBN (Fig. 2.6). A mathematical 
model based on this scheme and utilizing a single set of kinetic and equilibrium constants 
(some experimentally determined, some computationally inferred) was able to faithfully 
reproduce all the experimentally observed effects of changing either PhoBN or PAM 
concentration (Fig. 2.7).  
First, the difference between kphos (m) and kphos (het) accounted for the lag in the 
autophosphorylation time traces and deviation from a single phase exponential. 
Specifically, PhoB autophosphorylation kinetics were initially dominated by monomers 
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[kphos (m)] and hence slow. After creation of phosphorylated monomers facilitated 
heterodimer formation with an excess of unphosphorylated PhoB monomers, faster 
autophosphorylation kinetics [kphos (het)] became evident. The model predicted that under 
the experimental conditions employed, there was a flux from monomers through 
heterodimers to homodimers, but not necessarily a large accumulation of heterodimers. 
Second, a predicted dimerization constant [Kdimer (het)] for heterodimer formation in the 
same range as the protein concentration used in the experiments accounted for the protein 
concentration dependence of the normalized PhoBN time traces observed in Fig. 2.2D. 
Changing PhoBN concentration around Kdimer (het) altered heterodimer formation and 
hence the experimentally measured rate constants for the reaction. Additional insights 
gleaned from the mathematical model into the detailed mechanism of PhoB positive 
cooperativity are described in the next two sections. 
2.5.2 Dimerization constant for the PhoBN-P:PhoBN heterodimer was in the low 
micromolar range 
A surprising prediction from the kinetic modeling was that the dimerization 
constant for formation of the PhoBN-P:PhoBN heterodimer [Kdimer (het), 12 µM] was 
similar to that measured for formation of the PhoBN-P:PhoBN-P homodimer [Kdimer 
(hom), 5.1 µM (61)]. Receiver domain phosphorylation results in a conserved allosteric 
activating conformational change that includes changes in the α4-β5-α5 surface (10,24). 
For multiple response regulators in the OmpR/PhoB family, the changes in the α4-β5-α5 
surface result in formation of a dimer (10,24,33-35). Thus, it might be expected that 
acquisition of the active conformation is a prerequisite for dimerization and that 
formation of a PhoB heterodimer would involve association of a phosphorylated PhoB 
 54 
monomer with an unphosphorylated monomer that is in the active conformation. In such 
a circumstance, Kdimer (het) would be a composite of both the equilibrium constants for 
the conformational change and for dimerization [linked equilibria (80)], described by 
Kdimer,link in equation 2.5, where Kdimer,link is the apparent dimerization constant for 
heterodimer formation, Kconf is the conformational equilibrium constant for PhoB in the 
active conformation and Kdimer,act is the associative dimerization constant of PhoB in the 
active conformation: 
 
K#5$6,85%  K9: · K#5$6,9< 
 
Though it is difficult to measure the fraction of the response regulator population 
in the active conformation, it is estimated that no more than 10% of unphosphorylated 
response regulator molecules are in the active conformation (27,40).  Therefore, if Kconf is 
less than 0.1, we would predict Kdimer (het) to be at least 10-fold larger than Kdimer (hom), 
which does not contain a significant conformational component because the 
phosphorylated monomers are predominantly in the active conformation. The similarity 
between the predicted Kdimer (het) and the measured Kdimer (hom) suggests that acquisition 
of the active conformation is not a prerequisite for PhoB heterodimer formation. Though 
there is no direct evidence for the formation of a PhoBN heterodimer, a modified version 
of dimer 1 has been crystallized in the absence of BeF3¯  (60). Both monomers in the 
structure were in the inactive conformation, implying that PhoBN dimer 1 formation does 
not require acquisition of the active conformation before association.  
[2.5]
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2.5.3 Accelerated autophosphorylation of the PhoBN-P:PhoBN heterodimer 
The second important prediction from the mathematical modeling of PhoBN 
autophosphorylation was that the rate constant for phosphorylation of the heterodimer 
[kphos (het)] was approximately ten times higher than the rate constant for 
phosphorylation of the monomer [kphos (m)], implying that formation of the heterodimer 
of PhoBN enhanced the rate of autophosphorylation. This result is consistent with other 
observations that have linked an activated conformation to faster autophosphorylation 
kinetics. Addition of FliM [a ligand that pushes CheY towards an active-like 
conformation (29)] to CheY greatly enhances the rate of autophosphorylation compared 
to when no ligand is present (40). Similarly, addition of DNA that binds to OmpR 
increases the rate of autophosphorylation compared to no ligand present (41). We 
propose that formation of the heterodimer of PhoBN pushes the conformational 
equilibrium of the unphosphorylated monomer in the heterodimer towards the active 
conformation, which results in a faster rate of autophosphorylation of the PhoBN 
heterodimer compared to the PhoBN monomer. 
2.5.4 Physiological implications of cooperative kinetics 
We have presented extensive yet indirect evidence for formation of a PhoB 
heterodimer. It is not presently known if other response regulators form heterodimers, 
and, if so, whether heterodimer formation leads to enhanced phosphorylation kinetics. 
However, there is at least one published observation consistent with heterodimer 
formation by another response regulator. An apparent heterodimer of ComE was trapped 
by cross-linking and separated from cross-linked homodimer by SDS-PAGE (81).  
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How the network properties of different two-component systems can result in 
different output behaviors, including all-or-none versus graded responses, is the focus of 
both theoretical and experimental studies (82,83). Response regulators that form 
heterodimers with enhanced phosphorylation kinetics may contribute to an all-or-none 
output response. Our data demonstrating that phosphotransfer from the sensor kinase 
PhoR to PhoB was enhanced by dimer 1 formation (Fig. 2.8) would predict a sigmoidal 
relationship between phosphorylated PhoR (PhoR-P) and phosphorylated PhoB (PhoB-P) 
(i.e. a sudden nonlinear output response over a small change in input). PhoB is an 
autoregulated response regulator, where PhoB-P regulates transcription of both phoR and 
phoB, leading to a positive feedback loop for phoB regulation (84). In combination, the 
positive cooperativity and auto-regulation could lead to a physiological response that acts 
as an on/off switch. At low concentrations of PhoR-P, there would be little PhoB-P and 
thus a low level of transcriptional activation within the cell. Eventually, a threshold 
concentration of PhoR-P will be reached and PhoB-P will abruptly accumulate, leading to 
an abrupt cellular response. There is precedent for such behavior in the all-or-none 
response of PhoB to phosphorylation by non-cognate histidine kinases (85). Because the 
PhoRB system regulates transcription of genes encoding proteins involved in phosphorus 
assimilation, the potential on/off switch may act as a way to dampen responses to minor 
fluctuations in the environmental concentration of phosphate. 
Because formation of dimer 1 of PhoB orients the DNA-binding domains to 
interact with the symmetric DNA-binding sites (62), it is possible that a PhoB 
heterodimer would have similar affinity for DNA and thus could regulate transcription in 
vivo. A recent study that characterizes the relationship betw
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phosphorylated PhoB concentrations in vivo and transcriptional activity showed that, 
even at full transcriptional activity, the concentration of phosphorylated PhoB was less 
than the total concentration of PhoB (63). Although there are multiple explanations for 
this phenomenon, it could be due to a physiologically active heterodimer. If the 
heterodimer is active in vivo, there are many potential consequences. First, because the 
heterodimer only requires phosphorylation of a single monomer of PhoB, it will 
accumulate at lower concentrations of PhoB-P than the homodimer, leading to an 
increased sensitivity of response for the heterodimer. Second, some response regulators 
[e.g. OmpR (86), BvgA (87), NtrC (88)] bind to different promoters with different 
affinities, which allows step-wise responses to changing environmental circumstances. 
High affinity promoters are populated at low response regulator concentrations and 
promoters with low binding affinities are not populated until the concentration of 
response regulator is sufficiently high. The PhoB heterodimer and homodimer might 
exhibit different promoter binding affinities, which would facilitate a more complex 
regulatory scheme. Third, when the cellular signal is turned off, dephosphorylation of the 
PhoB homodimer may result in a functional heterodimer that can induce transcription for 
a longer timeframe than if no active heterodimer is formed. 
2.5.5 Autophosphorylation of PhoBN was different than CheY 
Positive cooperativity was not the only parameter that differed between CheY and 
PhoB. Although CheY autophosphorylation was 15-30 times faster than PhoBN 
autophosphorylation, PhoBN appeared to bind PAM slightly tighter than CheY. Based on 
our mathematical modeling, PAM binds to both the heterodimer and the monomer with 
binding constants [KS (het), KS (m)] of approximately 150 mM, whereas the PAM 
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binding affinity for CheY is estimated to be greater than 500 mM (40,42,46). These 
differences in rate and binding constants were noteworthy due to the similarities in 
tertiary structure, active site geometry, and divalent metal coordination of PhoBN and 
CheY. There must be other characteristics that differ between PhoBN and CheY that can 
explain the differences in rate and binding constants. One hypothesis based on work on 
CheY where positions near to the site of phosphorylation were substituted is that a more 
positive charge at the active site leads to faster autophosphorylation kinetics (46). We 
looked at the electrostatic surface potential of the Mg2+-bound forms of PhoBN [PDB 
2IYN (60)] and CheY [PDB 2CHE (89)] using Adaptive Poisson-Boltzman Solver 
software (90). The surface of CheY is more positively charged than PhoBN due to 
residues with varying charges in nonconserved positions structurally adjacent to the 
active site. Because the small-molecule phosphodonor is intrinsically negatively charged, 
the overall positive charge of the surface of CheY may lead to the faster rate of 
autophosphorylation compared to PhoBN. 
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2.6 Figures 
 
Figure 2.1. Ribbon representation of the physiologically relevant PhoBN dimer 
(dimer 1). The crystal structure shown is of PhoBN bound to the phosphoryl group 
analog BeF3¯  (PDBid 1ZES). The two (βα)5 monomers that comprise the dimer are 
colored blue (1ZES chain B) and cyan (1ZES chain C). Phosphoryl group analog BeF3¯  
(yellow and white) is bound to Asp53 (green). Also shown are the active site magnesium 
ion (black sphere) and the side chain for the Trp54 fluorophore (magenta). The dimer 1 
interface (pink circle) is comprised of residues on helix α4, strand β5, and helix α5 and 
includes Arg115 (light grey). The non-physiological dimer 2 interface (orange circle) is 
comprised of residues on helix α1, β5α5 loop, and helix α5 and includes Phe20 (dark 
grey). 
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Figure 2.2. Normalized CheY and PhoBN autophosphorylation time traces at 
various substrate or protein concentrations. Fluorescence measurement of 
autophosphorylation of 5 µM CheY (A) and 5 µM PhoBN (B) at the following PAM 
concentrations: 10 mM (purple), 20 mM (grey), 40 mM (dark blue), 60 mM (light blue), 
80 mM (orange), 100 mM (green), 125 mM (black), and 150 mM (red). Insets show a 
magnified view of the first portions of the autophosphorylation time traces. (C) 
Autophosphorylation of 2.5 µM (green), 5 µM (orange), and 10 µM (purple) CheY with 
60 mM PAM. (D) Autophosphorylation of 2.5 µM (green), 5 µM (orange), 10 µM 
(purple), 15 µM (red), and 20 µM (blue) PhoBN with 60 mM PAM. RFI (relative 
fluorescence intensity) is obtained by dividing all fluorescence intensities by the initial 
fluorescence intensity. Reactions were carried out in duplicate for panels A and C and in 
triplicate for panels B and D. Time traces represent the mean of multiple reactions. 
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Figure 2.3. Analysis of CheY and PhoBN time traces by fitting to a single exponential 
decay.  Autophosphorylation time traces for reaction of 5 µM CheY (A) or 5 µM PhoBN 
(B) with 60 mM PAM (grey) fit to a one-phase exponential decay (dashed black line). 
The rate constant from the fit is kobs for CheY and kapp for PhoBN. Residuals (the 
difference between the raw data and the fit) are shown below. Time traces represent the 
mean of multiple reactions. RFI is as defined in Figure 2.2. (C) Plot of kobs versus PAM 
concentration for 5 µM CheY fit with linear regression (see equation 2.3). The slope of 
the line gave kphos/KS and the y-intercept gave kdephos. Error bars represent standard 
deviation from duplicate experiments. (D) Plot of kapp versus PAM concentration for 5 
µM PhoBN fit with sigmoidal dose response curve (see equation 2.4). Error bars represent 
standard deviation from triplicate experiments.   
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Figure 2.4. Autophosphorylation kinetics of wild type PhoB (PhoBF and PhoBN) and 
PhoBN dimer interface mutants. (A) Autophosphorylation time traces for reaction of 5 
µM PhoBF (green), 5 µM PhoBN F20D (blue), 5 µM PhoBN R115D (purple), or 5 µM 
PhoBN (red, from Figure 2.2B) with 60 mM PAM. Inset: expanded timescale to show the 
full autophosphorylation time trace for PhoBN R115D. PhoBF contains a tryptophan in 
the output domain that is not present in PhoBN, leading to a smaller maximal quench in 
fluorescence for PhoBF. Time traces represent the mean of three reactions, with standard 
deviations (not shown for clarity) that were less than 3% of the mean. RFI same as 
defined in Figure 2.2. (B) Plot of kapp versus PAM concentration for 5 µM PhoBF (green 
triangles), 5 µM PhoBN F20D (blue diamonds), 5 µM PhoBN R115D (purple circles), or 5 
µM PhoBN (red squares, Figure 2.3D) fit with sigmoidal dose response curve (see 
equation 2.4) for PhoBF and PhoBN F20D or linear regression (see equation 2.3) for 
PhoBN R115D. Error bars represent standard deviation from triplicate experiments. 
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Figure 2.5. Beryllium trifluoride binding to PhoB constructs. Beryllium chloride 
titration with 5 µM PhoBN (square), 5 µM PhoBN F20D (circle), or 5 µM PhoBN R115D 
(triangle) measured by fluorescence. The buffer contains 10 mM NaF. Error bars 
represent standard deviation from triplicate experiments. 
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Figure 2.6. Model linking PhoBN heterodimer formation and autophosphorylation. 
A monomer of PhoBN binds a small molecule phosphodonor (PhoB·PAM) and 
phosphorylates (PhoB−P). The phosphorylated monomer can bind another 
phosphorylated monomer to form a homodimer. The phosphorylated monomer can also 
bind an unphosphorylated monomer to form a heterodimer, which can then bind PAM 
and phosphorylate. All three phosphorylated species of PhoBN can autodephosphorylate. 
Rate and equilibrium constants predicted by mathematical modeling included by 
corresponding arrows. Kinetic constants marked with a star (*) were measured 
experimentally. 
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Figure 2.7. Mathematical modeling by global kinetic analysis of 
autophosphorylation of PhoBN. Autophosphorylation time traces for reaction of 2.5-20 
µM PhoBN with 60 mM PAM (A) and for reaction of 5 µM PhoBN with 10-150 mM 
PAM truncated to 500 s (B) with overlays of modeled fits from global kinetic analysis by 
Dynafit (black dashed lines) and residuals. Colors in panel A as described in Figure 2.2D. 
Colors in panel B as described in Figure 2.2B. RFIP represents the normalized tryptophan 
fluorescence intensity obtained by dividing all fluorescence intensities by the initial 
fluorescence intensity then multiplying by the protein concentration. RFI in the residual 
plots is the same as defined in Figure 2.2. 
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Figure 2.8. Phosphotransfer from [32P]PhoR-P to either wild type PhoBN or PhoBN 
R115D. (A) Phosphorimage of SDS-PAGE gel analysis of phosphotransfer reactions. 
Each lane represents a different time point between 0-600 seconds as shown. (B) 
Quantitative analysis of the phosphorimage as shown in panel A for wild type PhoBN 
(squares) and PhoBN R115D (triangles), fit to a one-phase exponential decay. Each point 
represents the average and standard deviation of replicate experiments.
  
 
Chapter 3 – Substitutions at nonconserved active site residues affect the rates of 
PhoBN autophosphorylation 
 
3.1 Introduction 
 As discussed in Chapters 1 and 2, response regulators can autophosphorylate with 
small-molecule phosphodonors. Because typical antibiotics are small-molecule inhibitors 
of proteins or enzymes, better understanding of the interaction between response 
regulators and small-molecule phosphodonors may inform the search for or design of 
compounds with enhanced affinity for response regulators. For CheY, the relationship 
between the observed rate of autophosphorylation and the concentration of small-
molecule phosphodonor is linear up to the highest concentrations of phosphodonor tested 
(100 mM), indicating very weak substrate binding (KS> 500 mM) (40,42,46). Four 
nonconserved residues are predicted to form the surface of the response regulator active 
site where the small-molecule phosphodonor approaches and docks to the response 
regulator. Amino acid substitutions made at these positions in CheY greatly affected the 
rate of autophosphorylation with different phosphodonors; however the relationship 
between kobs and phosphodonor concentration remained linear, even for mutants with a 
103-104-fold rate enhancement (46) (Immormino, R.M, & Bourret, R.B., unpublished). 
Because small-molecule inhibitors must bind tightly to target proteins, CheY is not a 
good model system for better understanding of small molecule binding to response 
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regulators. Autophosphorylation of the response regulator PhoB, however, appeared to 
saturate at high concentrations of PAM (see Chapter 2). Apparent saturation of 
autophosphorylation of PhoB implies measurable binding of small molecules to PhoB. 
PhoB potentially offers an opportunity not available with CheY to gain a better 
understanding of the factors that determine the specificity and affinity of small molecule 
binding to response regulators. 
Here, we present kinetic characterization of autophosphorylation of mutants of the 
response regulator PhoB with the phosphodonors PAM and MPI. PhoBN substitutions 
were based on previously characterized substitutions in CheY as well as two previously 
uncharacterized positions inspired by small molecule docking into a crystal structure of 
PhoBN. The mathematical model described in Chapter 2 was utilized to predict which 
kinetic constants in the autophosphorylation mechanism are affected by the PhoBN 
substitutions. It is predicted that the PhoBN substitutions only affected the rates of 
phosphorylation and had no affect on small molecule binding or dimerization. 
 
3.2 Experimental Procedures 
3.2.1 Docking of small-molecule phosphodonors into PhoBN crystal structure 
The prodrg server (http://davapc1.bioch.dundee.ac.uk/prodrg/) was used to 
generate the atomic coordinates for MPI, PAM, and AcP. Water molecules were removed 
from the BeF3- and Mg2+-bound PhoBN crystal structure (PDBid 1ZES). The Docking 
Wizard utility in the Pymol Molecular Graphics System (Schrodinger, LLC) was used to 
do a three-on-three point docking of each small-molecule phosphodonor onto the PhoBN 
crystal structure. The atoms used for docking were the three fluorine atoms of BeF3- and 
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the three oxygen atoms of the phosphoryl group of the small-molecule phosphodonor, 
with the small-molecule phosphodonor leaving group oriented towards the solvent. The 
torsional angles of MPI and AcP were manually rotated to dock all three potential 
rotamers. Hydrogen atoms were added to each of the resultant protein-small molecule 
structures using Reduce (91). Pymol was used to select residues within 4 Å of the small-
molecule phosphodonor to identify residues that potentially interact with the small 
molecule. 
3.2.2 Previously described experimental procedures 
Cloning and site-directed mutagenesis of PhoBN was performed as described in 
Section 2.3.1 and resultant proteins were purified as in Section 2.3.3. The potassium salt 
of PAM was synthesized as described in Section 2.3.2. The sodium salt of MPI was 
synthesized as described (46,92). Autophosphorylation kinetics of PhoBN mutants with 
PAM (10-150 mM final concentration) and MPI (2.5-50 mM final concentration) were 
measured and processed as described in sections 2.3.6 and 2.3.7, respectively.  
3.2.3 Modified mathematical modeling 
 Mathematical modeling of autophosphorylation kinetics of PhoBN mutants with 
PAM was performed as in Section 2.3.8 with the following modifications. As before, four 
parameters were fixed using experimentally determined values. The six remaining rate 
and equilibrium constants were set to the values determined in Chapter 2 for 
autophosphorylation of wild type PhoBN. Nonlinear least-square regressions were 
performed to allow a subset of the rate and equilibrium constants to change: i) kphos (m), 
kphos (het), and kagg (m), ii) KS (m), KS (het), and kagg (m), iii) kphos (m), kphos (het), KS 
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(m), KS (het), and kagg (m), iv) kphos (m), kphos (het), KS (m), KS (het), Kdimer (het), and kagg 
(m).  
 
3.3 Results 
3.3.1 Substitutions at nonconserved active site residues 
 Docking of small-molecule phosphodonors into the crystal structure of BeF3--
bound PhoBN identified six nonconserved active site residues that might interact with the 
phosphodonors: Glu 11 (one residue C-terminal to the two conserved acidic residues, 
DD+1), Met 55 (two residues C-terminal to the conserved Asp, D+2), Leu 56 (three 
residues C-terminal to the conserved Asp D+3), Leu 82 (one residue N-terminal to the 
conserved Thr, T-1), Ala 84 (one residue C-terminal to the conserved Thr, T+1), Arg 85 
(two residues C-terminal to the conserved Thr, T+2) [Figure 3.1]. Nine substitutions were 
made at one or more of these six residues (Table 3.1) to determine if any of the residues 
affected small-molecule phosphodonor binding to PhoBN. The effects of two of these 
residues on CheY autophosphorylation have not been previously characterized (D+3 and 
T-1); therefore, initial substitutions to Ala were made to determine if removal of the side 
chains affected autophosphorylation. The four remaining residues predicted to interact 
with the phosphodonor have been previously characterized in CheY (46), (Immormino, 
R.M, & Bourret, R.B., unpublished). Previous characterization of substitutions at DD+1 
in CheY showed no effect on autophosphorylation kinetics (46). To determine if DD+1 
had an effect on PhoBN autophosphorylation, this residue was substituted to Ala.  
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Table 3.1. PhoBN substitutions 
Position Wild type residue(s) Substitution(s) Nomenclature 
11 (DD+1) Glu Ala PhoBN 11EA 
55 (D+2) Met Asp PhoBN 55MD 
 Met Asn PhoBN 55MN 
56 (D+3) Leu Ala PhoBN 56LA 
82 (T-1) Leu Ala PhoBN 82LA 
84 (T+1) Ala Thr PhoBN 84AT 
55 (D+2) 85 (T+2) Met   Arg Asn   Glu PhoBN NE 
 Met   Arg Asn   Tyr PhoBN NY 
 Met   Arg Lys    Tyr PhoBN KY 
 
The six remaining PhoBN substitutions were based on previously characterized 
substitutions in CheY :  
• A class of phosphatases within the haloacid dehalogenase superfamily of enzymes 
(HAD phosphatases) has a tertiary structure and active site that are highly similar to 
response regulators. HAD phosphatases catalyze the same phosphorylation and 
dephosphorylation chemistry as response regulators, but with rate constants ~103-104-
fold greater than the rate constants for response regulators (93). Substitutions made in 
CheY to mimic the HAD phosphatase active site (Asp at D+2, Arg at T+2) resulted in 
greatly enhanced rates of autophosphorylation and autodephosphorylation 
(Immormino, R.M, Starbird, C., Silversmith, R.E., & Bourret, R.B., unpublished). 
Because PhoBN already has an Arg at T+2, a single substitution was made at D+2 to 
an Asp to mimic the HAD phosphatase active site. To test whether the Asp at D+2 
acts through acid/base catalysis, D+2 was also substituted to an Asn, which contains 
an amide instead of a reactive carboxylic acid.  
• Based on an analysis of response regulator amino acid sequences, T+1 is typically 
occupied by a small amino acid like Ala or Gly [~73%], though sometimes a Ser/Thr 
is found at the T+1 position [15%] (Immormino, R.M, & Bourret, R.B., unpublished). 
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In CheY, incorporation of the larger, branched Thr side chain partially occludes the 
site of phosphorylation from small-molecule phosphodonors (Immormino, R.M, & 
Bourret, R.B., unpublished), decreasing the rate of autophosphorylation. To 
determine if this result occurs in another response regulator, T+1 in PhoBN was 
substituted to a Thr. 
• Finally, we made three double substitutions at D+2 and T+2. The first double mutant 
is a mimic of CheY with as Asn at D+2 and a Glu at T+2. The other two double 
mutants include the residues that resulted in the fastest autophosphorylation kinetics 
for CheY, Asn at D+2 and Tyr at T+2 or Lys at D+2 and Tyr at T+2 (46). 
3.3.2 Initial characterization of autophosphorylation of PhoBN mutants with PAM 
To begin characterizing autophosphorylation of the nine PhoBN mutants, we first 
monitored autophosphorylation at a single PAM concentration (60 mM) [Figure 3.2]. 
Any PhoBN mutants with obvious differences from wild type would be further 
characterized at multiple PAM and protein concentrations. Four of the substitutions 
(PhoBN 11EA, PhoBN 55MN, PhoBN NY, PhoBN KY) did not appear to affect 
autophosphorylation at 60 mM PAM, giving time traces that were similar to wild type 
PhoBN. Two of the mutants (PhoBN 56LA, PhoBN NE) showed no change in fluorescence 
intensity upon addition of PAM, possibly due to a non-functioning protein or a rate of 
autodephosphorylation that is much larger than the rate of autophosphorylation, resulting 
in no accumulation of phosphoryl group on the protein. The rate of 
autodephosphorylation of PhoBN NE was 0.24 min-1 (Stephani Page, Pers. Comm.), 
which is 15-fold faster than wild type PhoBN, suggesting that PhoBN NE was unable to 
accumulate phosphoryl groups. Three substitutions appeared to significantly affect the 
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apparent rate of PhoBN autophosphorylation. PhoBN 55MD exhibited a greatly enhanced 
apparent rate of PhoBN autophosphorylation in comparison to wild type PhoBN, whereas 
PhoBN 82LA and PhoBN 84AT had reduced apparent rates of PhoBN 
autophosphorylation.  
3.3.3 Full characterization of autophosphorylation of PhoBN mutants with PAM 
 In addition to the three mutants (PhoBN 55MD, PhoBN 82LA, PhoBN 84AT) that 
differed substantially from wildtype autophosphorylation at 60 mM PAM, we chose to 
further characterize PhoBN 55MN and PhoBN KY. PhoBN 55MN was examined for 
comparison to PhoBN 55MD and PhoBN KY was of interest due to the greatly enhanced 
rate of autophosphorylation for the same substitutions in CheY. For all five substitutions, 
we monitored autophosphorylation of 5 µM PhoBN with 10-150 mM PAM and 2.5-20 
µM PhoBN with 60 mM PAM. Preliminary results showed that precipitation of PhoBN 
82LA was an issue due to the length of time required to get a full time trace for 
autophosphorylation; therefore, it was not possible to obtain a full data set. 
Autophosphorylation of PhoBN 55MN and PhoBN KY resulted in time traces and plots of 
kapp versus PAM concentration that were very similar to wild type PhoBN (data not 
shown). Autophosphorylation of PhoBN 55MD gave normalized time traces that reached 
equilibrium much more quickly than wild type PhoBN for all PAM and protein 
concentrations (Figure 3.3AB). Autophosphorylation of PhoBN 84AT gave normalized 
time traces that reached equilibrium much more slowly than wild type PhoBN for all 
PAM and protein concentrations (Figure 3.4AB).  
For both PhoBN 55MD and PhoBN 84AT, the autophosphorylation time traces 
exhibited a visible lag at the beginning of the time traces similar to wild type PhoBN. For 
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both PhoBN 55MD (Figure 3.3C) and PhoBN 84AT (Figure 3.4C), plots of kapp versus 
PAM concentration fit to a sigmoidal curve with Hill coefficients of 1.6 ± 0.2 and 1.6 ± 
0.3, respectively, implying positive cooperativity of autophosphorylation similar to wild 
type PhoBN. However, the maximal apparent rate was much larger for PhoBN 55MD and 
much smaller for PhoBN 84AT than for wild type PhoBN. 
3.3.4 Mathematical modeling of PhoBN 55MD and PhoBN 84AT 
 In an attempt to understand the differences in autophosphorylation kinetics for 
PhoBN 55MD and PhoBN 84AT, we utilized the mathematical model described in 
Chapter 2 (Figure 2.5) to predict which kinetic parameters are affected by the 
substitutions. Four parameters were fixed to experimentally determined values and the six 
remaining rate and equilibrium constants were set to the values determined in Chapter 2 
for autophosphorylation of wild type PhoBN (see Chapter 2, Table 3.2). Dynafit was used 
to modulate a subset of the kinetic parameters in an attempt to globally fit the mutant 
autophosphorylation kinetic data. It was possible to adequately fit the PhoBN 55MD 
autophosphorylation data by changing just kphos (m), kphos (het), and kagg (m) [Figure 
3.5A, Table 3.2]. In contrast, it was not possible to fit the PhoBN 55MD 
autophosphorylation data by changing just KS (m), KS (het) and kagg (m) [Figure 3.5B, 
Table 3.2]. Allowing Dynafit to modulate other combinations of the parameters [e.g. kphos 
(m), kphos (het), KS (m), KS (het), and kagg (m)] did not increase the goodness of fit 
compared to modulating just kphos (m), kphos (het), and kagg (m) [data not shown]. Dynafit 
predicted that kphos (m) and kphos (het) for autophosphorylation of PhoBN 55MD with 
PAM were approximately 30-fold higher than for autophosphorylation of wild type 
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PhoBN. Furthermore, kphos (m) and kphos (het) were changed to a similar extent and kphos 
(het) remained approximately 10-fold higher than kphos (m).  
 
Table 3.2. Rate constants predicted by mathematical modeling for PhoBN 
55MD and PhoBN 84AT. 
 kphos (m) 
[s-1] 
kphos (het) 
[s-1] 
KS (m) 
[mM] 
KS (het) 
[mM] 
kagg (m)  
[s-1] 
Wild type 0.018 0.14 160 140  2.3x10-3  
55MD: kphos 0.53 4.9 --- --- 1.9x10-6  
84AT: kphos 0.0051 0.080 --- --- 5.6x10-4  
 
Similarly, it was possible to satisfactorily fit the data for autophosphorylation of 
PhoBN 84AT by changing just kphos (m), kphos (het), and kagg (m) [Figure 3.6, Table 3.2]. 
Dynafit predicted that kphos (m) and kphos (het) for autophosphorylation of PhoBN 84AT 
with PAM were approximately 1/2 to 1/3 of the value for wild type PhoBN. Furthermore, 
kphos (m) and kphos (het) were changed to a similar extent and kphos (het) was 
approximately 10-fold higher than kphos (m). Because the mathematical model was able to 
account for the changes in the PhoBN 55MD and PhoBN 84AT autophosphorylation data 
compared to wild type by only changing kphos (m), kphos (het), and kagg (m) [Figure 3.5A, 
Table 3.2], we predict that the 55MD and the 84AT substitutions greatly affected the 
rates of phosphorylation. However, it appears that neither the 55MD nor the 84AT 
substitution affected PAM binding. 
In order to achieve a satisfactory global fit for all PAM autophosphorylation data 
with wild type PhoBN, it was necessary to include a slow aggregation step in the 
mathematical model (see Section 2.3.8 of Chapter 2).  In particular, the plateau RFI 
values observed in the two of 12 experimental conditions with the longest time traces 
were not as high as expected, a discrepancy attributed to light scattering by aggregates.  
 76 
The values of kagg predicted for PhoBN 55MD and PhoBN 84AT were substantially 
different than for wild type PhoBN, presumably due to different experimental conditions.  
kagg for PhoBN 55MD was three orders of magnitude smaller than for wild type PhoBN, a 
difference consistent with the much faster autophosphorylation kinetics (and hence less 
opportunity for aggregate formation) of the mutant.  We did not attempt to fit the PhoBN 
55MD data without the aggregation step, but it may be possible to do so.  In contrast, the 
PhoBN 84AT autophosphorylation reactions were slower than those of PhoBN conducted 
under analogous conditions.  As a result, aggregation potentially affected many more 
experimental conditions for PhoBN 84AT than wild type PhoBN (cf. length of time 
courses in Figures 2.2BD and 3.4AB).  Therefore, the kagg value predicted from fitting the 
PhoBN data (~1/4 of the kagg value predicted from wild type PhoBN) may be more 
accurate than that derived from analysis of the wild type PhoBN data. 
3.3.5 Optimization of PhoBN autophosphorylation with MPI 
 Mathematical modeling predicted that the 55MD and 84AT substitutions did not 
affect PAM binding to PhoBN. However, the leaving group for PAM is just ammonia 
(Table 1.1), which does not offer much surface area for interaction with the side chains of 
nonconserved active site residues in PhoBN. Therefore, we chose to monitor PhoBN 
autophosphorylation with MPI to see if a larger leaving group revealed changes in small 
molecule binding to PhoBN. Initial characterization of autophosphorylation of wild type 
PhoBN with 1.5 mM MnCl2 and MPI resulted in no quench in fluorescence intensity, 
suggesting that PhoBN cannot autophosphorylate with Mn2+ and MPI. However, Mg2+ 
was able to support autophosphorylation of PhoBN with MPI. Autophosphorylation of 
wild type and mutant CheY with MPI is faster than autophosphorylation with PAM 
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(45,46), so we anticipated that precipitation due to the presence of Mg2+ would not be an 
issue within the timescale of the PhoBN autophosphorylation reactions with MPI.  
 Autophosphorylation of PhoBN 55MD was measured with PAM and 20 mM 
MgCl2 to determine whether changing the divalent cation from Mn2+ to Mg2+ affected 
autophosphorylation kinetics. It was not possible to measure autophosphorylation of wild 
type PhoBN with MgCl2 and PAM due to precipitation issues; however, 
autophosphorylation of PhoBN 55MD occurred over a fast enough timescale to measure 
autophosphorylation prior to precipitation occurring. Because, for any given PAM 
concentration, kobs was two- to three-fold faster for 20 mM MgCl2 compared to 1.5 mM 
MnCl2 (Figure 3.7), any large effects on PhoBN autophosphorylation with MPI and 
MgCl2 should not be due to a change in the divalent cation. 
3.3.6 Autophosphorylation of wild type PhoBN with MPI and Mg2+ 
 Autophosphorylation of wild type PhoBN was monitored with varying 
concentrations of MPI (2.5-50 mM) [Figure 3.8A]. It was not possible to measure 
autophosphorylation with higher concentrations of MPI due to precipitation. The 
autophosphorylation time traces exhibited a visible lag at the beginning of the time traces 
similar to autophosphorylation with PAM. A plot of kapp versus PAM concentration for 
autophosphorylation of wild type PhoBN with MPI also fit to a sigmoidal curve with a 
Hill coefficient of 1.6 ± 0.4 (Figure 3.8B), implying positive cooperativity of 
autophosphorylation with MPI similar to autophosphorylation with PAM. A plot of kapp 
versus phosphodonor concentration for wild type PhoBN with MPI was about two- to 
three-fold faster than with PAM (data not shown).  
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3.3.7 Initial characterization of autophosphorylation of PhoBN mutants with MPI 
As we did with PAM, we began characterizing autophosphorylation of the nine 
PhoBN mutants by monitoring autophosphorylation at a single MPI concentration (30 
mM) [Figure 3.9]. Again, the same four substitutions (PhoBN 11EA, PhoBN 55MN, 
PhoBN NY, PhoBN KY) did not appear to affect autophosphorylation at 30 mM MPI, and 
gave time traces that were similar to wild type PhoBN. Also similar to 
autophosphorylation with PAM, addition of MPI to PhoBN 56LA or PhoBN NE did not 
result in a change in fluorescence intensity. The apparent rates of autophosphorylation of 
PhoBN 82LA and PhoBN 84AT were again reduced compared to wild type PhoBN; 
however, PhoBN 84AT had a slower apparent rate of autophosphorylation than PhoBN 
82LA. This was reversed from autophosphorylation with PAM, where PhoBN 82LA had 
a slower apparent rate of autophosphorylation than PhoBN 84AT.  
The most surprising result from the initial characterization with 30 mM MPI was 
that PhoBN 55MD had an apparent rate of autophosphorylation that was similar to wild 
type PhoBN. The normalized time trace for autophosphorylation of PhoBN 55MD with 30 
mM MPI had a much smaller change in fluorescence intensity than autophosphorylation 
of PhoBN 55MD with PAM or wild type PhoBN with PAM or MPI. The rate of 
autodephosphorylation of PhoBN 55MD [kdephos (55MD) = 0.036 s-1] was much faster 
than wild type PhoBN [kdephos (WT) = 0.0003 s-1] (data not shown). If the apparent rates of 
autophosphorylation of wild type PhoBN and PhoBN 55MD are indeed similar as is 
suggested by autophosphorylation with 30 mM MPI, then the enhanced rate of 
autodephosphorylation would result in fewer phosphoryl groups accumulating on PhoBN 
55MD, resulting in a smaller change in fluorescence intensity. 
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Full characterization of autophosphorylation of the PhoBN mutants was not 
possible at this time. Because autophosphorylation with MPI requires the use of Mg2+, 
precipitation was a major issue at high concentrations of MPI and for long reaction times. 
Furthermore, preparation of MPI involves a multi-step organic synthesis that requires 
removal of contaminating reactants and byproducts (e.g. PAM, DPI). Consecutive 
preparations of MPI were inconsistent and resulted in varying levels of remaining 
contaminant. Further work is required to optimize both the preparation of MPI and the 
protocol for PhoBN autophosphorylation with MPI. 
 
3.4 Discussion 
To date, response regulator autophosphorylation has been extensively 
characterized for only CheY and PhoB. Previous characterization of autophosphorylation 
of CheY mutants with varying small molecule phosphodonors resulted in apparent rate 
constants that varied linearly with respect to small molecule phosphodonor concentration 
(46) (Immormino, R.M, & Bourret, R.B., unpublished), indicating weak substrate 
binding. PhoBN autophosphorylation, on the other hand, appears to saturate at high PAM 
concentrations (see Chapter 2). We took advantage of this apparent saturability to 
determine if a set of substitutions within the PhoBN active site had an effect on small 
molecule phosphodonor binding to PhoBN. None of the substitutions tested affected PAM 
binding to PhoBN; however, further experiments are needed to determine if the 
substitutions have an effect on MPI binding. 
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3.4.1 Comparison of PhoB mutants and CheY mutants 
 Four of the six nonconserved active site positions substituted here in PhoBN were 
previously characterized in CheY (DD+1, D+2, T+1, T+2). To compare the effects of 
substitutions in PhoBN and CheY, the rate constants of the PhoBN mutants are compared 
to that of wild type PhoBN, and the rate constants of the CheY mutants are compared to 
that of a CheY mutant that mimics the wild type PhoBN active site by containing the 
PhoB residues Asp at D+2, Ala at T+1, and Arg at T+2. All of the substitutions 
characterized here had similar effects in PhoBN and CheY. Though the same substitutions 
were not made in CheY and PhoBN, all substitutions at DD+1 in PhoBN (PhoBN 11EA) 
[Figure 3.2] and CheY (46) had no effect on autophosphorylation kinetics with multiple 
small molecule phosphodonors. Substituting a Thr at T+1 for an Ala in both PhoBN 
(PhoBN 84AT) and CheY (46) gave slightly slower autophosphorylation with PAM 
(Figure 3.2) and much slower autophosphorylation with MPI (Figure 3.9) compared to 
wild type. It is predicted that the planar imidazole ring of MPI clashed with the branched 
Thr side chain at position T+1 (Immormino, R.M, & Bourret, R.B., unpublished), 
resulting in the greatly reduced autophosphorylation rate constant. 
 Substitutions at positions D+2 and T+2 resulted in similar changes in rate 
constants for autophosphorylation in PhoBN and CheY. The substitutions in CheY with 
the greatest enhancement in autophosphorylation with PAM contain an Asp at D+2 and 
an Arg at T+2 [CheY DR] (Immormino, R.M, Starbird, C., Silversmith, R.E., & Bourret, 
R.B., unpublished). The rate constant for autophosphorylation of CheY DR with PAM is 
12-fold faster than for the CheY mutant containing wild type PhoB residues at D+2 and 
T+2 (CheY MR). Because PhoBN already contains an Arg at T+2, a single substitution 
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was made at position D+2 (PhoBN 55MD) to give the same pair of residues as CheY DR. 
Mathematical modeling predicted that PhoBN 55MD had rate constants for 
phosphorylation with PAM that were enhanced approximately 30-fold over wild type 
(Table 3.2). In contrast, the 55MD substitution did not appear to affect the apparent rate 
of autophosphorylation with 30 mM MPI compared to wild type PhoBN (Figure 3.9). 
Autophosphorylation of CheY DR with MPI has not been measured; however, docking of 
MPI into the crystal structure of CheY DR (Figure 3.10 A) predicts steric clashes 
between the Asp and Arg side chains and the imidazole ring of MPI that are not predicted 
with PAM (Figure 3.10 B).  
Substituting D+2 with an Asn (PhoBN 55MN) gave apparent PAM 
autophosphorylation kinetics that were similar to wild type PhoBN (Figures 3.2, 3.9), 
suggesting that the carboxylic acid of Asp at D+2 affects the chemistry of 
autophosphorylation. The effects on PhoBN autophosphorylation of Asn versus Asp at 
D+2 results were similar to previous observations with CheY.  In particular, CheY 
mutants bearing an Arg at T+2 and either an Asn (like PhoBN MN) or Met (like wild type 
PhoBN) at D+2 exhibited similar rate constants for PAM autophosphorylation, and both 
values of kphos were an order of magnitude smaller than for CheY DR (3). 
 The three PhoBN double mutants at positions D+2 and T+2 potentially had similar 
affects as were seen in CheY. The CheY mimic at positions D+2 and T+2 (PhoBN NE) 
showed no change in fluorescence upon addition of PAM (Figure 3.2) or MPI (Figure 
3.10). Autophosphorylation of wild type CheY with PAM is slower than 
autophosphorylation of CheY MR (46) and autodephosphorylation of wild type CheY is 
faster than autodephosphorylation of CheY MR (94). Similarly, PhoBN NE has a much 
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faster rate of autodephosphorylation than wild type PhoBN (Stephani Page, Pers. Comm.). 
Therefore, if autophosphorylation of PhoBN NE is slower than autophosphorylation of 
wild type PhoBN, we would expect any phosphoryl group that binds to PhoBN NE to be 
immediately removed, resulting in no accumulation of phosphoryl group and no change 
in fluorescence. 
 Finally, PhoBN NY and PhoBN KY both had autophosphorylation kinetics that 
were similar to wild type PhoBN with both PAM (Figure 3.2) and MPI (Figure 3.9). 
Although CheY NY and CheY KY had rate constants for autophosphorylation that were 
much larger than wild type CheY, CheY NY, CheY KY, and CheY MR all had 
autophosphorylation kinetics that varied only approximately five-fold (46). Based on 
docking of MPI into the crystal structure of CheY *KY, there are stabilizing pi-pi 
interactions between the imidazole ring and the T+2 Tyr side chain (46). Although Arg is 
not able to form as strong pi-pi interactions as the aromatic Tyr side chain, Arg is still 
able to form moderate pi-pi interactions, possibly explaining the moderate changes in 
autophosphorylation between wild type PhoBN and PhoBN NY/PhoBN KY. 
3.4.2 Previously uncharacterized substitutions 
 Two substitutions presented here (PhoBN 56LA and PhoBN 82LA) have not been 
previously characterized in CheY. PhoBN 56LA showed no change in fluorescence upon 
addition of phosphodonor, suggesting that PhoBN 56LA was unable to accumulate 
phosphoryl groups (Figure 3.2, 3.9). PhoBN 82LA had slower apparent rates of 
autophosphorylation than wild type PhoBN (Figure 3.2, 3.9); however, PhoBN 82LA 
precipitated during autophosphorylation experiments. Further analysis of the small 
molecule phosphodonor docked PhoBN crystal structure (Figure 3.1) showed that the side 
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chains of positions 56 and 82 are not close to the site of phosphorylation and it is likely 
that the main chain was predicted to interact with the phosphodonor. PhoBN 56LA and 
PhoBN 82LA likely affected the stability of the protein as opposed to phosphorylation 
chemistry. 
3.4.3 Small molecule phosphodonor binding to PhoBN 
Mathematical modeling was used to model the autophosphorylation kinetics of 
four of the PhoBN mutants, PhoBN 55MD (Figure 3.5), PhoBN 55MN (data not shown), 
PhoBN KY (data not shown), and PhoBN 84AT (Figure 3.6). Modeling of the 
autophosphorylation kinetics predicted that none of the substitutions tested affected small 
molecule binding to PhoBN. However, full characterization of autophosphorylation 
kinetics of these mutants were with the phosphodonor PAM, which has a small side chain 
that likely does not interact with the side chains of the PhoBN active site residues. The 
larger leaving group of MPI might allow for more interaction between the small molecule 
phosphodonor and the side chains of PhoBN. However, measuring autophosphorylation of 
PhoBN with MPI was complicated by inconsistent MPI preparations and precipitation due 
to the use of Mg2+. Optimization of both the MPI preparation and the protocol for PhoBN 
autophosphorylation with MPI is feasible; however, it may be time intensive. If no effects 
on MPI binding to PhoBN are observed for this set of mutants, other residues could be 
manipulated to identify potential interfaces involved in small molecule phosphodonor 
binding. 
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3.5 Figures 
 
Figure 3.1. Model of AcP docked into the active site of PhoBN·BeF3- structure 
(PDBid 1ZES). Small-molecule phosphodonor AcP (carbon – green, oxygen – red, 
phosphorus - red) is bound to Asp53 (pink). Residues previously characterized in CheY 
(46) (unpublished data) are shown in blue. Residues that have not been previously 
substituted in CheY are shown in yellow. 
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Figure 3.2. Autophosphorylation of nine PhoBN mutants with 60 mM PAM and 1.5 
mM MnCl2. Overlay of wild type PhoBN (WT PhoBN) from Figure 2.2B shown for 
comparison. 
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Figure 3.3. Characterization of PhoBN 55MD autophosphorylation. (A) Fluorescence 
measurement of autophosphorylation of 5 µM PhoBN 55MD with 10-150 mM PAM 
concentrations. Colors in panel A as described in Figure 2.2B. (B) Autophosphorylation 
of 2.5-20 µM PhoBN 55MD with 60 mM PAM. Colors in panel B as described in Figure 
2.2D. Reactions in panels A and B were performed in duplicate. RFI is as defined in 
Figure 2.2. (C) Plot of kapp versus concentration of PAM for 5 µM PhoBN 55MD (red) 
and 5 µM PhoBN as shown in Figure 2.3D for comparison (blue) fit with sigmoidal dose 
response curve (equation 3.4). Error bars represent standard deviation from duplicate 
experiments. Most error bars in panels C and D were smaller than data points. 
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Figure 3.4. Characterization of PhoBN 84AT autophosphorylation. (A) Fluorescence 
measurement of autophosphorylation of 5 µM PhoBN 84AT with 10-150 mM PAM 
concentrations. Colors in panel A as described in Figure 2.2B. (B) Autophosphorylation 
of 2.5-20 µM PhoBN 84AT with 60 mM PAM. Colors in panel B as described in Figure 
2.2D. Reactions in panels A and B were performed in duplicate. RFI is as defined in 
Figure 2.2. (C) Plot of kapp versus concentration of PAM for 5 µM PhoBN 84AT (red) and 
5 µM PhoBN as shown in Figure 2.3D for comparison (blue) fit with sigmoidal dose 
response curve (equation 3.4). Error bars represent standard deviation from duplicate 
experiments. Most error bars in panels C and D were smaller than data points. 
 
  
  
 
Figure 3.5. Mathematical modeling by global kinetic analysis of 
autophosphorylation of PhoBN 55MD. Autophosphorylation time traces for reaction of 
20 µM (pink), 15 µM (grey), 10 µM (orange), and 2.5 µM (red) PhoBN 55MD with 60 
mM PAM and for reaction of 5 µM PhoBN 55MD with 10 mM (dark purple), 20 mM 
(light blue), 40 mM (dark green), 60 mM (light purple), 80 mM (mustard), 100 mM 
(black), 125 mM (dark blue), and 150 mM (lime green) PAM truncated to 20 s. Insets of 
first 5 s of reactions of 5 µM PhoBN 55MD with varying concentrations of PAM. 
Overlays of modeled fits from global kinetic analysis by Dynafit (black dashed lines) and 
residuals for modulation of kphos (m), kphos (het), and kagg (m) [A] or modulation of KS 
(m), KS (het), kagg (m) [B]. RFIP as described in Figure 2.7. RFI as defined in Figure 2.2. 
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Figure 3.6. Mathematical modeling by global kinetic analysis of 
autophosphorylation of PhoBN 84AT. Autophosphorylation time traces for reaction of 
2.5-20 PhoBN 84AT with 60 mM PAM and for reaction of 5 µM PhoBN 84AT with 10-
150 mM PAM truncated to 1000 s. Colors as defined in Figure 3.5. Insets of first 300 s of 
reactions of 5 µM PhoBN 84AT with varying concentrations of PAM. Overlays of 
modeled fits from global kinetic analysis by Dynafit (black dashed lines) and residuals 
for modulation of kphos (m), kphos (het), and kagg (m). RFIP as described in Figure 2.7. RFI 
as defined in Figure 2.2. 
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Figure 3.7. Autophosphorylation of PhoBN 55MD with Mn2+ or Mg2+. Plot of kapp 
versus PAM concentration for 5 µM PhoBN 55MD  with 1.5 mM MnCl2 (orange) or 20 
mM MgCl2 (green) fit with sigmoidal dose response curve (equation 3.4). Error bars 
represent standard deviation from duplicate experiments. 
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Figure 3.8. Autophosphorylation of wild type PhoBN with MPI. (A) Fluorescence 
measurement of autophosphorylation of 5 µM wild type PhoBN with 2.5 mM (purple), 5 
mM (grey), 10 mM (dark blue), 15 mM (light blue), 20 mM (orange), 30 mM (green), 40 
mM (black), and 50 mM (red) MPI. (B) Plot of kapp versus MPI concentration for 5 µM 
PhoBN fit with sigmoidal dose response curve (equation 3.4). Error bars represent 
standard deviation from duplicate experiments. 
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Figure 3.9. Autophosphorylation of nine PhoBN mutants with 30 mM MPI and 20 
mM MgCl2. Overlay of wild type PhoBN (WT) from Figure 3.8A shown for comparison. 
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Figure 3.10. Model of phosphodonors docked into the active site of CheY DR·BeF3- 
structure (PDBid 3RVL).  Small-molecule phosphodonor MPI (A) and PAM (B) and 
side chains of  59D and 89R shown as spheres. 
 
  
  
 
Chapter 4 – Experimentally monitoring heterodimer formation 
 
4.1 Mechanisms of PhoB phosphorylation and dimerization 
 As discussed in Chapter 2, there is an apparent link between dimerization and 
autophosphorylation of PhoB. There are at least four potential mechanisms linking 
autophosphorylation and dimerization [Figure 4.1]: i) two phosphorylated monomers 
dimerize to form a homodimer [Figure 4.1 A], ii) two unphosphorylated monomers 
dimerize to form an apo dimer and subsequently phosphorylate [Figure 4.1 B], iii) one 
phosphorylated monomer and one unphosphorylated monomer dimerize to form a 
heterodimer and the second monomer phosphorylates [Figure 4.1 C], iv) dimerization and 
phosphorylation occur simultaneously. It is possible that more than one mechanism 
occurs in nature, even within the same response regulator. The current dogma and 
widespread belief in the field is that phosphorylation occurs prior to dimerization [Figure 
4.1 A] (95,96).  
However, there are multiple pieces of evidence suggesting that PhoBN 
dimerization occurs via multiple mechanisms (see Chapter 2). Both nondimerizing 
response regulators (e.g. CheY) and a PhoBN mutant that is unable to dimerize (PhoBN 
R115D) are able to phosphorylate, indicating that dimerization is not a prerequisite for 
phosphorylation (Figure 4.1 B) and that phosphorylation and dimerization do not occur 
simultaneously. Mathematical modeling of PhoBN autophosphorylation suggests that 
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both the homodimer and the heterodimer form during autophosphorylation reactions. 
Furthermore, formation of the PhoBN heterodimer enhances the rate of phosphotransfer 
from the sensor kinase PhoR compared to the PhoBN monomer, further indicating that 
PhoBN dimerization can occur via a heterodimer. It is not presently known if other 
response regulators form heterodimers, and, if so, whether heterodimer formation leads to 
enhanced autophosphorylation kinetics similar to PhoBN. However, an apparent 
heterodimer of the ComE response regulator was trapped by cross-linking and separated 
from cross-linked homodimer by SDS-PAGE (81).  
 The experiments described in Chapter 2 were not capable of directly observing 
PhoBN heterodimer formation. Experimental evidence of heterodimers might further 
elucidate mechanistic information about the link between response regulator 
phosphorylation and dimerization. Furthermore, experimentally measuring the 
dimerization constant for heterodimer formation [Kdimer (het)] would lead to even better 
understanding of response regulator heterodimers. To be able to experimentally observe 
heterodimers, it will be necessary to either separate the heterodimer and homodimer 
populations or to watch the formation of heterodimers by isolating phosphorylated 
monomers without formation of homodimers. 
 
4.2 Strategies for experimentally monitoring heterodimer formation 
4.2.1 Gel electrophoresis 
 Using gel electrophoresis to separate populations of proteins has the potential to 
separate heterodimers from homodimers. Cross-linking of proteins followed by SDS-
PAGE is one example of using gel electrophoresis to experimentally observe 
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heterodimers. Because heterodimers readily phosphorylate and form homodimers in the 
presence of excess phosphodonor, it will be necessary to phosphorylate PhoBN with low 
phosphodonor concentrations for any subsequent experiments. Under these conditions, 
most of the protein will be present as an unphosphorylated monomer, but the low level of 
phosphorylation should allow for both heterodimer and homodimer formation. After 
PhoBN is incubated with phosphodonor, heterodimers and homodimers may be trapped 
using a chemical cross-linker and potentially separated using SDS-PAGE. In theory, 
SDS-PAGE should remove the charge differences between the homodimer and the 
heterodimer; however, it has been shown previously that the extra phosphoryl group may 
change the migration of the heterodimer and the homodimer, allowing for separation 
(81). 
 An advantage of using cross-linking and gel electrophoresis to distinguish 
between PhoBN dimers is that no special or expensive equipment is required. However, 
optimization of cross-linking (e.g. which reagent to use and what concentration of cross-
linker is required) and phosphorylation (e.g. phosphodonor concentration and reaction 
time) reaction conditions could be very time intensive and difficult. Also, because SDS-
PAGE separates proteins solely by size, it is only possible to determine the molecular 
weight of the proteins of interest and assumptions must be made about what 
phosphorylation states are being observed. Finally, because cross-linking only has the 
potential to separate the heterodimer from the homodimer, it is not possible to measure 
Kdimer (het).  
 It may be possible to overcome some of the complications of using chemical 
cross-linking and SDS-PAGE to separate the heterodimer from the homodimer by using a 
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gel that allows for separation of proteins based on the presence of phosphorylated 
residues. Phos-tag acrylamide (Wako Pure Chemical Industries, Inc.) forms a specific 
noncovalent complex with phosphomonoester dianions, leading to slower migration of 
phosphorylated proteins in the gel. Phos-tag acrylamide has been shown to interact with 
phosphorylated response regulators, including PhoB (56,63,78,95). Using Phos-tag 
acrylamide to separate heterodimers and homodimers would be better than using cross-
linking because it does not require modification of the proteins. However, the technique 
is very finicky and out lab has not had success using Phos-tag acrylamide. 
4.2.2 Surface plasmon resonance 
Another way to experimentally monitor PhoBN heterodimer formation would be 
to isolate phosphorylated PhoBN monomer and then add unphosphorylated monomer. 
However, because phosphorylated monomers readily form homodimers, it would be 
necessary to isolate PhoBN monomers prior to phosphorylation and then allow for 
heterodimer formation. One technique that may be utilized to observe heterodimers and 
potentially measure Kdimer (het) is surface plasmon resonance [SPR] (97). SPR uses optics 
near a metal buffer interface to determine the interactions between a ligand and an 
analyte due to changes in the refractive index of the interface surface. A ligand is 
immobilized on a sensor chip (Figure 4.2 A) and a constant flow of buffer is passed over 
the chip. After a stable baseline is reached for the ligand alone, buffer containing the 
second binding partner is passed over the chip allowing for association of the analyte to 
the ligand (Figure 4.3 B). After the association phase, the initial buffer is passed over the 
chip to allow for dissociation of the analyte from the ligand. To monitor heterodimer 
formation, this protocol would need to be modified slightly: a monomer of PhoBN would 
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be bound to the chip and subsequently phosphorylated with a small-molecule 
phosphodonor, then nonphosphorylated PhoBN would be flowed over the chip, 
potentially allowing for heterodimer formation without competing formation of 
phosphorylated homodimers.  
 Using SPR to monitor PhoBN heterodimer formation has many advantages. First, 
because association of PhoBN monomers is measured in real time, it may be possible to 
measure Kdimer (het). Also, SPR does not require any special residue or protein 
modification so experiments can be performed with wild type protein. Because no special 
residues or protein modifications are required, SPR can potentially be used to monitor 
dimerization of any dimerizing response regulator. However, there are also many 
drawbacks to using SPR to monitor PhoBN heterodimer formation. The major limitation 
to SPR is due to the depletion of analyte molecules as they travel from one end of the 
sensor chip to the other, called mass transport. To accurately measure binding kinetics, all 
ligand molecules in the system should have a constant amount of analyte available for 
binding, which cannot occur if the analyte molecules are depleted due to reaction with the 
first few ligand molecules. Also, SPR is very expensive (with sensor chips costing 
hundreds of dollars apiece) and requires specialized equipment, although a BiaCore 
instrument is available at UNC. 
4.2.3 Biolayer interferometry 
 Another technique that can potentially isolate PhoBN monomers prior to 
phosphorylation and potentially measure Kdimer (het) is biolayer interferometry [BLI] 
(98). BLI measures the interference pattern of white light reflected from two surfaces 
(Figure 4.3 A): an internal reference layer and the end of the sensor tip (e.g. immobilized 
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protein). Binding of ligand to the immobilized protein changes the interference pattern 
due to an increase in optical thickness on the sensor tip and is reported in units of 
wavelength nm shift (Figure 4.3 B). BLI can potentially be used similarly to SPR to 
monitor heterodimer formation: a monomer is bound to a sensor tip, phosphorylated, and 
then allowed to bind to nonphosphorylated monomer, potentially forming a heterodimer.  
There are many advantages to using BLI to monitor heterodimer formation. First, 
the equipment (both the machine and the fiber optic biosensor tip) required is much less 
expensive than the equipment for SPR. Second, BLI is performed in a 96-well plate and it 
is possible to monitor eight interactions in parallel, reducing the time required for the 
experiments. Third, the sensor tip is moved into the analyte-containing solution, 
removing the potential for mass transport issues that are seen with SPR. Finally, large 
scale preparations can be performed to bind the ligand to the sensor tip away from the 
machine. However, there are two major disadvantages to using BLI to monitor 
heterodimer formation. First, BLI is a new technique and there are still issues with 
immobilization and sensitivity that need to be worked out in initial experiments. Also, the 
sensitivity of BLI is less than the sensitivity of SPR and BLI cannot be used to measure 
interactions of small ligands and analytes. 
 
4.3 Preliminary experiments using BLI 
 We chose to try to monitor PhoBN heterodimer formation using BLI because BLI 
has the potential to monitor both heterodimer formation and measure Kdimer (het) and is 
less expensive and faster than SPR. We established a collaboration with Jonathan 
McMurry at Kennesaw State University in Kennesaw, GA to use his ForteBio Octet QK 
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biosensor using Nickel·NTA sensors. Because the protocol we plan to use to monitor 
heterodimer formation includes a chemistry step (autophosphorylation followed by 
washing the sensor tip to remove unreacted phosphodonor) and is different from 
published BLI protocols (99,100), I went to Kennesaw State University to optimize our 
protocol. I tried to bind purified His6-tagged PhoBN, His6-tagged PhoBF, His6-tagged 
PhoBN F20D, and His6-tagged PhoBN R115D to the Nickel·NTA sensors. I saw initial 
binding of protein to the sensor tips; however, the protein washed off of the tips. We are 
currently working on cloning the genes for the PhoB variants into vectors containing 
different affinity tags (e.g. biotin-tag to bind to streptavidin tips or GST-tag to bind to 
anti-GST tips) to potentially get higher affinity protein binding to sensor tips. 
 
4.4 Potential outcomes from BLI experiments 
4.4.1 – Implications of BLI experiments 
 The BLI experiments described above might allow for direct observation of 
PhoBN heterodimers; however, it may not be possible to monitor heterodimer formation 
using BLI. The inability of monitoring heterodimer formation using BLI may be due to 
flaws in the BLI experiments. Because the biocompatible surface on the biosensor tip is 
densely packed, the phosphorylated PhoBN monomers may be able to form homodimers 
on the tip. Also, because the sensitivity of BLI is less than the sensitivity of SPR, it may 
not be possible to monitor interactions between proteins as small as PhoBN (~14.5 kDa). 
An inability to monitor heterodimer formation may also be because our model accounting 
for the PhoBN autophosphorylation data is wrong and PhoBN may not be able to form 
heterodimers. 
 101 
If it is possible to monitor heterodimer formation using BLI, it may also be 
possible to experimentally measure Kdimer (het). We will be able to compare the 
experimental value for Kdimer (het) to the value predicted by modeling to test the accuracy 
of the mathematical model. We will also be able to plug the experimentally determined 
Kdimer (het) into the mathematical model to further reduce the degrees of freedom. This 
will allow us to more accurately predict the remaining kinetic constants in the model [KS 
(m), kphos (m), KS (het), kphos (het)]. 
4.4.2 Interaction between receiver and DNA-binding domains may affect Kdimer (het) 
The potential to monitor PhoBN heterodimer formation and measure Kdimer (het) 
may lead to understanding of dimerization of other response regulators. We predict that 
there is a relationship between the extent of interdomain contacts between the receiver 
and DNA-binding domains of response regulators and the extent of heterodimer 
formation. Because crystallization of multi-domain proteins is difficult, we are aware of 
only four crystal structures of full-length, multi-domain response regulators. Three of the 
crystallized response regulators showed extensive interdomain contacts between the 
receiver domain and the DNA-binding domain: MtrA (101), PrrA (102), DrrB (103). In 
these response regulators, the α4-β5-α5 interface of the receiver domain makes the 
majority of the contacts with the DNA-binding domain. The interactions between the 
domains are thought to stabilize the inactive conformation because the physiologically 
relevant α4-β5-α5 interface is occluded. Furthermore, the interdomain contacts in DrrB 
(103) and MtrA (101) involve the conserved Tyr switch residue and this interaction must 
be broken for the response regulators to obtain the active conformation. Conformational 
rearrangements are thought to be the rate-limiting step of both autophosphorylation and 
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dimerization in response regulators with extensive interdomain contacts (78). Response 
regulators with extensive interactions between the receiver domain and the DNA-binding 
domain (MtrA, DrrB, PrrA) have slow rates of autophosphorylation and removal of the 
DNA-binding domain enhanced the rate of autophosphorylation at least nine-fold over 
full length protein (78).  
In contrast to MtrA, DrrB, and PrrA, the crystal structure of full-length DrrD did 
not show extensive interdomain contacts between the receiver and DNA-binding domains 
(104). Full-length DrrD and the receiver domain alone had similar observed rates of 
autophosphorylation (78), suggesting that there are limited interdomain contacts in the 
protein in solution. Similarly, autophosphorylation of PhoBF and PhoBN had similar rates 
of autophosphorylation (78) (Chapter 2), also suggesting minimal interdomain contacts in 
PhoB. 
 We predict that the extent of interdomain contacts between the receiver domain 
and the DNA-binding domain of response regulators will affect the extent of heterodimer 
formation. Because there are limited interactions to disrupt, response regulators with few 
interdomain contacts will likely be able to readily form heterodimers. The lack of 
interdomain contacts to break will likely result in a lower activation energy for 
heterodimer formation, suggesting that Kdimer (het) will be similar to Kdimer (hom) as 
suggested in Chapter 2 for PhoB. In contrast, we predict response regulators with 
extensive interdomain contacts between the receiver and DNA-binding domains will not 
readily make heterodimers. The interdomain contacts must be broken prior to 
heterodimer formation, resulting in a high activation energy for heterodimer formation. 
Because it will be necessary to break these contacts, we predict Kdimer (het) will be much 
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larger than Kdimer (hom) for response regulators with extensive interactions. Therefore, in 
such response regulators homodimer formation is likely to proceed through interaction of 
two phosphorylated monomers (Figure 4.1 A). 
4.4.3 DNA binding of heterodimers and homodimers 
 It is currently thought that two response regulator monomers phosphorylate and 
subsequently dimerize (Figure 4.1 A) allowing for interaction with symmetric DNA 
binding sites (95,96). A crystal structure of the PhoB DNA-binding domain in complex 
with the σ4 domain of the σ70 transcription initiation complex and the DNA binding site 
(pho box) showed that two DNA-binding domains interact with one σ4 domain (53), 
suggesting dimerization is important for transcription regulation. However, there is no 
evidence that the receiver domain interacts with the σ70 transcription initiation complex 
or the DNA binding site, suggesting that the phosphorylation state of the receiver 
domains should not affect DNA binding or transcription regulation. Because dimer 1 of 
PhoB orients the DNA-binding domains to interact with the symmetric DNA-binding 
sites (62), it is possible that a PhoB heterodimer would have similar affinity for DNA as a 
PhoB homodimer and thus could regulate transcription in vivo.  
 As discussed in Chapter 2, there is an apparent link between dimerization and 
autophosphorylation of PhoB; however, little is known about the link between 
dimerization and phosphorylation of response regulators in general. It is possible that all 
four mechanisms describing the relationship between phosphorylation and dimerization 
(Figure 4.1) are present in nature. Understanding the relationship between dimerization 
and phosphorylation of response regulators will require further investigation. 
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4.5 Figures 
 
Figure 4.1. Sequential modes of response regulator phosphorylation and 
dimerization. There are at least three mechanisms describing the relationship between 
unphosphorylated monomers (blue) and phosphorylated monomers (orange). (A) 
Phosphorylation of both monomers precedes dimerization. (B) Dimerization precedes 
phosphorylation of both monomers. (C) A single monomer is phosphorylated and binds 
an unphosphorylated monomer. The unphosphorylated monomer is subsequently 
phosphorylated. 
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Figure 4.2. Surface plasmon resonance. Modified from (105). (A) A ligand is 
immobilized on a sensor chip containing a metal buffer interface and a baseline SPR 
angle is monitored. (B) Binding of an analyte to the immobilized ligand is monitored, 
causing a change in the SPR angle. After the association phase, the initial buffer is passed 
over the chip to allow for dissociation of the analyte from the ligand and the SPR angle to 
return to baseline values. 
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Figure 4.3. Biolayer interferometry. Modified from (106). (A) BLI measures the 
interference pattern of white light reflected from two surfaces: an internal reference layer 
and the end of the sensor tip (e.g. immobilized protein). (B) Binding of ligand to the 
immobilized protein changes the interference pattern due to an increase in optical 
thickness on the sensor tip and is reported in units of wavelength nm shift.  
  
 
Chapter 5 – Conclusions and future directions 
 
5.1 Expanded knowledge of response regulator autophosphorylation kinetics 
 Prior to the work presented in this dissertation, CheY was the only response 
regulator for which extensively characterized autophosphorylation kinetics had been 
published (40,42,44,46). With the work presented here on autophosphorylation of PhoB, 
the number of response regulators with extensively characterized autophosphorylation 
kinetics measured has doubled to two. Response regulators have a highly conserved 
tertiary structure and a high degree of amino acid sequence similarity, including the 
perfectly conserved quintet of active site residues (23,25). This suggested that the 
fundamental characteristics of autophosphorylation and autodephosphorylation are likely 
to be very similar for all response regulators. Therefore, going into this dissertation work, 
we hypothesized that all response regulators catalyze autophosphorylation in a 
fundamentally similar way. Based on this hypothesis, we predicted that the characteristics 
of autophosphorylation of PhoB would be similar to CheY; however, that prediction was 
proven false. Autophosphorylation of PhoB with PAM and MPI was much slower than 
autophosphorylation of CheY. Also, autophosphorylation of CheY is nonsaturable with 
respect to small molecule phosphodonor concentration (40,42,44,46), whereas 
autophosphorylation of PhoB appears to both saturate at high phosphodonor 
concentrations and to have cooperative autophosphorylation kinetics (see Chapter 2). 
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These results suggest that there may be a link between autophosphorylation kinetics and 
the wide variety of response regulator functions. Response regulator 
autodephosphorylation rate constants span many orders of magnitude (94), setting a 
precedent for a wide range in autophosphorylation kinetics depending on response 
regulator function 
Though response regulators do not typically phosphorylate in vivo through 
autophosphorylation by small-molecule phosphodonors, are there any biological 
implications to different autophosphorylation kinetics for different response regulators? 
CheY is a response regulator in a chemotaxis-like signaling system whereas PhoB is a 
response regulator in a two-component system. Because chemotaxis is a very fast process 
that literally involves split second decisions (107), CheY may have evolved an active site 
that allows for very fast movement of phosphoryl groups (including by 
autophosphorylation) within the system. Chemotaxis evolved with monomeric response 
regulator and cannot introduce cooperativity to the chemotaxis system through 
dimerization of the response regulator. However, it is interesting to note that chemotaxis 
evolved cooperativity through another mechanism, e.g. the relationship between the input 
stimulus and the amount of CheY-P may be linear because the flagellar switch has a 
highly cooperative output response with respect to CheY-P concentration [Hill coefficient 
≈ 11 (108)]. 
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5.2 Speculation about range of response regulator autophosphorylation rate 
constants 
Because phosphorylation and dephosphorylation of response regulators are 
catalyzed by the same set of conserved active site residues, it may be reasonable to 
speculate about trends in autophosphorylation and phosphotransfer from sensor kinases 
based on trends in autodephosphorylation and phosphatase activity. Response regulators 
perform the chemistry of autodephosphorylation, whereas auxiliary phophatases act to 
help orient a water molecule rather than dephosphorylate the response regulator (7,109-
111). Two extremes in the range of possible relationships between autodephosphorylation 
rate constants and stimulatory effects of phosphatases are: i) all response regulators have 
the same autodephosphorylation rate constants and phosphotases stimulate 
dephosphorylation to the rate required for nature, ii) response regulators have greatly 
differing autodephosphorylation rate constants and phosphatases have mild stimulatory 
effects to fine-tune a system. Published response regulator autodephosphorylation rate 
constants span up to six orders of magnitude (66), which is much larger than the range of 
stimulatory effects of phophatases [often one to two orders of magnitude (7)], suggesting 
that response regulators have evolved autodephosphorylation rate constants that are near 
the timescale required for the biology of the system and that phosphatases fine-tune the 
dephosphorylation rate further.  
It is known that response regulators can catalyze autophosphorylation, but little is 
still known about the role sensor kinases play in the phosphotransfer reaction. Sensor 
kinases, among other possibilities, may act as a passive phosphodonor substrate, may 
contribute catalytic residues to enhance phosphorylation, or may provide a high local 
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concentration of phosphodonor to properly orient the phosphoryl group for chemistry. 
Again there are two extremes in the possible relationship between autophosphorylation 
and phosphotransfer are: i) response regulator autophosphorylation rate constants are 
similar and phosphotransfer rate constants vary greatly between systems, ii) 
autophosphorylation rate constants differ greatly and phosphotransfer rate constants with 
sensor kinases are similar. Published bimolecular rate constants for phosphotransfer from 
sensor kinases to response regulators are all similar and fast [>106 M-1 s-1 (64,112-114)]. 
Until we can measure autophosphorylation kinetics for many response regulators, 
mutants of well-characterized response regulators may provide the best hint of what the 
range of autophosphorylation rate constants might be for response regulators.  Analysis 
of autophosphorylation kinetics of mutants of CheY and PhoB [Table 3.2 and other work 
from our lab (46) (Immormino, R.M, Starbird, C., Silversmith, R.E., & Bourret, R.B., 
unpublished)] suggests an approximately three- to four-order of magnitude range in 
autophosphorylation rate constants.  
The relationship between autophosphorylation rate constants and phosphotransfer 
rates suggests that, as opposed to the relationship between autodephosphorylation and 
phosphatase stimulation, autophosphorylation rate constants differ greatly between 
response regulators whereas phosphotransfer rates with sensor kinases are similar. For 
dephosphorylation, there is a large range of autodephosphorylation rates and a small 
range of phosphatase stimulation, but the overall effect is to have a wide range of 
dephosphorylation rates presumably matching biological timescales. However, for 
phosphorylation, there appears to be a large range of autophosphorylation rates and a 
very small range in the absolute rates of phosphotransfer. From the limited 
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phosphotransfer data currently available, it appears that phosphotransfer from the sensor 
kinase is rapid, allowing for response regulators in different two-component systems to 
instantly respond to changes in stimuli. Furthermore, it appears that the kinetic control of 
two-component systems is through dephosphorylation. In other words, the concentration 
of phosphorylated response regulator (and thus the output of the system) may be 
determined by the balance between the rates of formation and destruction. It appears that 
the rate of formation is binary (very fast or totally off), whereas the rate of destruction 
(the lifetime of the phosphorylated response regulator) varies between systems. 
 
5.3 Mn2+ is able to support autophosphorylation of response regulators 
 A divalent cation bound in the receiver domain active site is required for catalysis 
of both response regulator phosphorylation and dephosphorylation (9,43). It was known 
that Mg2+, Mn2+, Zn2+, Co2+, and Cd2+ are able to support autodephosphorylation of 
CheY, but Ca2+ is not (9). However, prior to the work presented here, little was known 
about how different divalent cations are able to support response regulator 
phosphorylation reactions. Mn2+ supports autophosphorylation of the response regulator 
Spo0F with PAM (74), autophosphorylation of several sensor kinases, and 
phosphotransfer from a sensor kinase to a response regulator in vitro (75-77). Here we 
show that Mn2+ supports autophosphorylation of both CheY (Chapter 2) and PhoBN 
55MD (Chapter 3) to approximately the same extent as Mg2+. Although Mg2+ is most 
likely the divalent cation utilized by response regulators in vivo, Mg2+ and Mn2+ have 
similar size and preferred coordination number, geometry, and ligand type (73). 
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5.4 Apparent saturation of PhoB autophosphorylation may allow for differentiation 
between substrate binding and reaction chemistry 
For CheY, the relationship between the observed rate of autophosphorylation and 
the concentration of small-molecule phosphodonor is linear up to the highest 
concentrations of phosphodonor tested, indicating very weak substrate binding 
(40,42,46). For PhoB, however, the relationship between the apparent rate of 
autophosphorylation and the concentration of small-molecule phosphodonor appears to 
saturate at high concentrations of phosphodonor, indicating measurable binding of small 
molecules to PhoB. Binding of a non-hydrolyzable substrate analog (H3N+–PSO22-, 
SPAM) to PhoBN also suggested positive cooperativity of substrate binding (data not 
shown). Attempts were made to obtain co-crystals between SPAM and PhoBN to directly 
visualize small molecule binding to response regulators, but this strategy has not yet been 
successful. 
The apparent saturability of PhoB autophosphorylation potentially offers an 
opportunity not available with CheY to gain a better understanding of the factors that 
determine the specificity and affinity of small molecule binding to response regulators. It 
may be possible to determine residues that interact with small molecule phosphodonors in 
the background of PhoB. However, none of the substitutions made in PhoBN tested here 
affected small molecule phosphodonor binding to PhoBN as assessed by analysis of 
autophosphorylation kinetics (see Chapter 3). As an alternate approach, it may be 
possible to monitor SPAM binding to PhoBN mutants to determine which residues, if any, 
affect small molecule binding to PhoBN. Further experiments are needed to identify the 
determinants of small molecule phosphodonor binding to PhoB. 
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5.5 Heterodimer formation may play a role in response regulator phosphorylation 
 An exciting prediction from the kinetic modeling presented in Chapters 2 and 4 
was that PhoBN dimerization occurs through multiple mechanisms that include a 
heterodimer (one unphosphorylated monomer and one phosphorylated monomer) and a 
homodimer (two phosphorylated monomers). The kinetics predicted for PhoB 
heterodimer formation were on the same order of magnitude as those measured for 
formation of a PhoB homodimer. Could this be a general mechanism for response 
regulator dimerization? As described in Chapter 4, we predict that there is a relationship 
between the extent of heterodimer formation and the extent of interdomain contacts 
between the receiver domain and the DNA-binding domain of response regulators. 
Response regulators with few interdomain contacts [e.g. DrrD (104)] will likely be able 
to readily form heterodimers because there are few interactions that need to be disrupted 
prior to heterodimer formation. In contrast, response regulators with extensive 
interdomain contacts [e.g. MtrA (101), PrrA (102), DrrB (103)] likely will not readily 
form heterodimers due to the large number of contacts that need to be broken. Further 
characterization of response regulator interdomain interactions and dimerization is 
required to better understand the relationship. 
 The current dogma of the field is that two phosphorylated monomers 
phosphorylate and subsequently dimerize allowing for interaction with symmetric DNA 
binding sites (95,96). However, dimer 1 of PhoB orients the DNA-binding domains to 
interact with the symmetric DNA-binding sites (62). Furthermore, a crystal structure of 
the PhoB DNA-binding domain in complex with the DNA binding site and a portion of 
the transcription initiation complex showed that, while dimerization is important for 
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transcription regulation, the receiver domain likely does not participate. Therefore, it is 
possible that a PhoB heterodimer would have similar affinity for DNA as a PhoB 
homodimer and thus could regulate transcription in vivo. Understanding the relationship 
between phosphorylation, dimerization, and DNA-binding of response regulators will 
require further investigation. An initial approach is described in Chapter 4. 
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